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ABSTRACT 
For decades, astrocytes, the most numerous cell of the central nervous system, were 
considered to be passive supporters of nerve cell architecture and function, lacking 
excitability and having no role in signal integration. However, recent findings have 
progressively challenged that view, highlighting the active participation of astrocytes in 
synaptic transmission and information processing. This dissertation presents evidence for 
the major contribution of astrocytes in the modulation of neuronal excitability that is in 
large part mediated by the excitatory neurotransmitter glutamate. Neuroligands, ATP and 
SDF-la released glutamate from astrocytes that stimulated adjacent neurons by the 
NMDA-receptor activation. Furthermore, rapid bi-directional signaling loops between the 
neurons and glia have been revealed in experiments performed on co-cultures. 
In addition to its fundamental physiological importance, this dissertation postulates 
a new role for astrocytes in brain pathology. Cell culture experiments revealed a direct 
toxic effect of neurotoxins, gpl20, an HIV-1 envelope glycoprotein, and cannabinoids on 
astrocytes. A propensity of astrocytes to undergo apoptosis and to release excitotoxic 
glutamate in response to insult elicited by gpl20 and cannabinoids suggests that, along with 
neurons, astroglia are an important site of action for neurotoxins in brain. Potential 
mechanisms of cannabinoid toxicity include formation of ceramide and free radicals and 
activation of several primary and secondary effector enzymes. An indirect contribution of 
astrocytes to the gpl20 and cannabinoid-induced neuron injury is implied with this study. 
Potential mechanisms include disturbances of glia function and their ability to support 
ix 
neurons and the astrocytes-mediated excitotoxins formation in the brain. This part of the 
dissertation gave well-deserved respect to the issue of cannabinoid and gpl20 astrotoxicity 
because a better understanding of the pathogenesis of astrocytes in encephalopathies may 
have important therapeutic implications in the future. 
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CHAPTER 1. GENERAL INTRODUCTION 
The mammalian nervous system is composed of more than 100 billion neurons 
surrounded by glial cells. Glial cells outnumber the neurons 10-50:1. A generally accepted 
view is that glial cells are nothing more than passively subservient to neurons. The 
development and advances in monitors of intracellular ion concentration open a new field 
of cellular physiological investigation. With these technical advances, studies show that 
glial cells are much more complex entities than had been appreciated. 
The focus of this dissertation is twofold: first, the study of the effect of 
neuroligands, ATP and SDF-la, on astrocytes in order to further our understanding of 
astrocytes in brain function and second, the study of the effect of neurotoxins on astrocytes 
and the mechanism of astrotoxicity. 
Thesis organization 
This dissertation is composed of three journal papers. Each journal paper compromises 
a single chapter of the dissertation. The papers are preceded by a general introduction 
chapter containing a literature review, and followed by a general conclusion chapter 
consisting of a general discussion section and summary. References from all chapters are 
listed in a comprehensive listing at the end of the dissertation. 
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Literature Review 
Neuroglia 
Glial cells were first described in 1846 by German pathologist Rudolf Virchow who 
named them neuroglia (Greek, meaning nerve glue). In the vertebrates, glia can be divided 
into four major categories. In the peripheral nervous system (PNS) are the Schwann cells, 
and in the central nervous system (CNS) are the microglia, oligodendrocytes and astrocytes. 
Anatomists have divided normal astrocytes in the mature brain into two broad categories: 
fibrous astrocytes, which contains abundant intermediate filaments and are predominant in 
white matter, and protoplasmic astrocytes, which contain fewer filaments and are 
predominant in gray matter. The glial filaments are composed of glial fibrillary acidic 
protein (GFAP), a specific histochemical marker of astroglia. A third class known as 
reactive astrocytes appears following injury in the brain. An alternative view of glial 
subtypes has emerged from glial cell lineage studies in vitro. A compelling body of 
literature provided evidence that there are two lineages of astroglia cells in brain cell 
cultures designated as type I and type n astroglia (Raff et al., 1983). 
For a long time, it had been widely believed that neuroglia primarily played a 
supportive role in the functioning of the nervous system. There are well-documented roles 
for glia in the supply of nutrients to neurons (Pentreath et al., 1986), establishment and 
maintenance of the blood-brain barrier (Abbott, 1991), neuronal guidance (Rakic, 1971) 
and the control of extracellular K+ by locally removing K+ released from active neurons 
(Kufïler et al., 1966). Also, glia control a variety of other important processes in the CNS, 
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like regulation of glycogen metabolism (Phelps, 1972), control of CNS development 
(Rakic, 1990), repair of neural damage (Gilmore at al., 1982), and uptake of transmitters 
(Schousboe, 1981; Kimelberg and Katz, 1996). 
However, there is mounting evidence that glia in general, and astrocytes in 
particular, might play a much more central role in information processing in the brain 
(Barres, 1991; Kettenmann, 1996; Ullian et al., 2001). The two-way dialog, where 
astrocytes appear to communicate with neurons, leads to the possibility that astrocytes 
might play a key role in information processing (Attwell, 1994; Smith, 1994). This is 
further supported by the fact that astrocytes are targets of biologically active molecules. At 
the plasma membrane, both types of astroglia express numerous receptors for 
neurotransmitters, peptides, growth factors and hormones, like purinergic P2Y, histamine, 
bradykinin, adrenergic, and cholinergic receptors that regulate intracellular calcium levels 
(Murphy and Pearce, 1987; Dave and McCarthy, 1989; Finkbeiner, 1992; Hosli and Hosli, 
1993; Giaume and Venance, 1996). A variety of ion channels are expressed in astroglia, 
voltage-gated sodium and calcium channels and ligand-gated channels GAB A, AMP A, 
Kainate, and purinergic P2X as examples (Barres et al., 1990; Ritchie, 1992; Sontheimer, 
1992). This indicates astrocyte capability to sense most of the signals sensed by neurons. 
Similar to neuronal neurotransmitter receptors, astroglial receptors activate a 
number of second messenger systems including cyclic AMP (McCarthy and de Vellis, 
1978), phosphoinositide metabolism (Pearce et al., 1986), intracellular calcium (Salm et al., 
1990), and arachidonic acid (De George et al., 1986). Activation of these systems may, in 
turn, affect a number of physiological processes, including enzyme induction (Aizenman 
and de Vellis, 1987), proliferation (Morrison and de Vellis, 1981), membrane potential 
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(Bowman and Kimelberg, 1984), and neuromodulator secretion (Shain and Martin, 1984). 
It is also established that astrocytes respond to stimuli with release of chemical transmitters, 
like aspartate, glutamate, D-serine and ATP (Parpura et al., 1994; Schell et al., 1995; 
Jeftinija et al., 1996; Wang et al., 2000). 
Oligodendrocytes are glial cells that make and maintain myelin in the CNS. Other 
than supportive, their functions remain unknown. It is speculated that they might have an 
autocrine/paracrine function (Szuchet and Yim, 1990). Their counterparts in the PNS are 
the Schwann cells, which provide housing for axons within peripheral nerves. Similarly to 
oligodendrocytes, Schwann cells form myelin sheaths along the larger nerve fibers that 
allow saltatory conduction of nerve impulses, which increases the velocity of nerve 
conduction as much as 100 times. Beyond these basic functions, the Schwann cell is able to 
respond to nerve injury by helping to remove cellular debris, by facilitating the process of 
remyelination, and by promoting nerve fiber regeneration. Recent investigations 
documented a capability of Schwann cells to release the neurotransmitter glutamate in 
response to the neuroligands bradykinin and adenosine 5 tri phosphate (ATP) that might 
play a role in glia-neuron signaling in the peripheral nervous system (Parpura et al., 1995a; 
Jeftinija et al., 1998). 
Microglia, the other sub-type of neuroglia in the CNS, are often referred as sensors 
for pathological events in the brain. Their nature and identity have long been debated but it 
is now generally accepted that they are ontogenetically related to cells of the mononuclear 
phagocyte lineage, unlike all other cell types in the CNS. The most characteristic feature of 
microglial cells is the rapid activation in response to even minor pathological changes in the 
brain. They are a key factor in defense of the neural parenchyma against infectious diseases, 
5 
inflammation, trauma, ischemia, brain tumors and neurodegeneration (reviewed by 
Kreutzberg, 1996). Activated microglia can destroy invading microorganisms, remove 
debris, promote tissue repair by secreting growth factors and thus facilitate return to tissue 
homeostasis. Furthermore, microglia have receptors for CNS signaling molecules such as 
ATP, acetylcholine (Ach) and norepinephrine (Walz et al., 1993; Whittemore et al., 1993). 
Their ability to respond selectively to molecules involved in neurotransmission allows 
them, in their resting state, to monitor continuously the physiological integrity of their 
microenvironment and to react rapidly in the event of pathological disturbances. 
Glutamate Receptors and Transporters 
Glutamate is the major fast excitatory neurotransmitter in the mammalian central 
nervous system (Mayer and Westbrook, 1987). Upon stimulation glutamate is released from 
neural cells, astrocytes and neurons. Both type of cells express glutamate receptors. Two 
families of glutamate receptors have been cloned and characterized, G protein-coupled 
glutamate receptors also known as metabotropic receptors (mGluR) and an ion channel 
family of glutamate receptors. Until now eight receptors of the metabotropic class have 
been discovered and they have been classified into three groups based on their linkage to 
second messenger systems and their pharmacology. Each group has a distinct roles in the 
physiological and pathophysiological processes in the brain. Group I mGluR-receptors, 
which are coupled to Gq/u proteins, stimulate IP3/DAG formation and augment 
neurodegeneration mediated by the ionotropic glutamate receptors, whereas the Group II 
and Group III mGluR-receptors that modulate cAMP levels via Gi/0 proteins may be 
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neuroprotective (reviewed by Nicoletti et al., 1996). Modulation of synaptic transmission 
by mGluR-receptors has been also documented (Kilbride at al 1998; Wittmann et al., 2001). 
The ion channel family of glutamate receptors compromises 3 major subdivisions based 
on pharmacology and structural properties: NMDA (N-methyl-D-aspartate), AMPA (a-
amino-3-hydroxyl-5-methylisoxazole-4-propionic acid), and Kainate subtypes of ionotropic 
glutamate receptors. The NMDA receptor is a high conduction channel (50 ps), permeable 
for both cations, Na+ and Ca2+, and blocked by magnesium at membrane potentials close to 
resting, endowing a voltage dependence to this ligand-gated ion channel (Mayer and 
Westbrook, 1987; Nicol et al., 1988). NMDA receptors are post-synaptic and play an 
important roles in the development of the CNS, plasticity and excitotoxicity (Rothman and 
Olney, 1986; Cotman et al., 1988). AMPA receptors are cation-permeable channels (Na+/ 
K+ / Ca2+) that mediate chemical transmission at the majority of fast excitatory synapses in 
the CNS (Sheng and Lee, 2001). The role of kainate receptors is less clear however, a 
plethora of recent studies has altered this situation profoundly such that kainate receptors 
are now regarded as key players in the modulation of transmitter release, as important 
mediators of the postsynaptic actions of glutamate, and as possible targets for the 
development of antiepileptic and analgesic drugs (reviewed by Lerma et al., 2001). 
The glutamate transporters in the plasma membranes of neural cells secure termination 
of glutamatergic synaptic transmission and keep glutamate levels below toxic 
concentrations. Five homologous types of the Na+ / K+-dependent high-affinity glutamate 
transporters, termed GLAST (EAAT1), GLT1 (EAAT2), EAAC (EAAT3), EAAT4 and 
EAAT5, have been cloned recently from different species (reviewed by Gegelashvili and 
Schousboe, 1997). EAAC and EAAT5 are found exclusively in neurons (Yamada et al., 
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1996; Torp et al., 1997), whereas GLAST and GLT1, the major contributors to glutamate 
uptake, are glia-specific transporters (Rothstein et al., 1996). GLT1 predominates 
quantitatively and is responsible for most of the glutamate uptake activity in the juvenile 
and adult brain. 
Role of astrocytes in the control of synaptic transmission and neuronal excitability 
For years, glial cells were assumed to the silent cells that lacked excitability and had 
no role in signal integration in the brain. Recent findings challenged that view emphasizing 
the active contribution of astrocytes in synaptic transmission, both in vitro (Araque et al., 
1998a; Ulian et al., 2001) and in situ (Pasti et al., 1997). A study by Newman et al. (1998) 
showed that Ca2+ elevations within glial cells of the retina can modulate information 
transfer from photoreceptors to retinal ganglion cells. This modulatory action provides 
compelling evidence that glial Ca2+ signals are intimately involved in the regulation of 
information processing in the nervous system. Astrocytes can transmit messages to 
surrounding cells by the direct release of signaling molecules such as the excitatory 
neurotransmitter glutamate that excites neurons (Nedergaard, 1994; Parpura et al., 1994; 
Jeftinija et al., 1996; Bezzi et al., 1998; Jeremic et al., 2001). In addition, astrocytes 
transmit messages to other cells by producing transcellular messengers including 
eicosanoids (Piomelli, 1994) and nitric oxide (Murphy et al., 1993). 
Astrocytes may have opposite effects on the synapse; they can elicit a mGluR-
dependent depression (Araque et al., 1998a) or an NMDA-receptor-dependent increase in 
neurotransmitter release (Araque et al., 1998b). Highly plastic, bi-directional signaling 
loops between astrocytes and neurons have been documented at both central (Pasti et al., 
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1997) and peripheral synapses (Robitaille et al., 1998). Based on these insights, a new view 
emerged that the brain should no longer be regarded as a complex array of neuronal 
networks, but instead of integrated circuits of interactive neurons and glia (Bezzi and 
Volterra, 2001). 
The role of glia and glutamate in the brain pathology 
Damage to the central nervous system leads to cellular changes not only in the neural 
cells (neurons and glia) but also in endothelial cells and the cells of the immune system. 
Traumatic injury to the CNS results in a rapid response from resident astrocytes, a process 
often referred to as reactive astrogliosis or glial scarring. This neuroglial activation is a 
consistent feature in almost all forms of brain pathology and appears to reflect an 
evolutionary-conserved program which plays an important role for the repair of the injured 
nervous system (Raivich et al., 1999). It is still debated whether these reactions of glia to 
insult are beneficial or detrimental for the brain. It is believed that the reactive astrogliosis 
observed in most neurological disorders may regulate the removal of toxic compounds by 
damaged neurons and support neuronal growth by releasing trophic factors (Tacconi, 1998). 
However, it has also been suggested that astrocytes contribute to the decline of neurological 
function by accumulating and releasing excitotoxic amino acids after ischemia or oxidative 
stress, increasing in neuronal [Ca2+]j and free radicals and releasing arachidonic acid and 
pro-inflammatory cytokines. (Shivachar et al., 1996; Ashner, 1998; Tacconi, 1998; Sastry 
and Rao, 2000). 
Glutamate has gained additional attention due to recent observations showing that 
endogenous glutamate is toxic to neurons when it accumulates in the extracellular space in 
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the brain. Pathological activation of glutamate receptors is thought to be a final common 
pathway leading to neuronal damage in the course of many neurological diseases such as 
hypoxic-ischemic brain injury, epilepsy, Huntington's disease, Parkinson's disease, 
Alzheimer's disease, and HIV-associated dementia. Brain damage, during ischemia and 
other pathological events, is now thought to be partly due to the inappropriate release of 
EAAs such as L-Glu and L-Asp, which, through activation of EAA receptors, cause death 
of certain neurons (Choi, 1988; Faden et al., 1989). Reversal of glutamate transporters in an 
experimental paradigms that mimic severe ischemia led to extracellular glutamate 
accumulation and subsequent neuronal death in hippocampal slices (Rosi et al., 2000). 
Perhaps the most compelling argument implicating glutamate toxicity in induced neural 
injury is the finding that glutamate antagonists, in particular NMDA antagonists, are 
neuroprotective in a variety of paradigms (Rothman, 1983; Weiss et al., 1986; Goldberg et 
al., 1987). 
Many of the external factors such as bacterial and viral infections, toxins and drugs 
of abuse induce apoptosis of neurons and glia in vitro. This is the prominent feature of 
many brain disorders in vivo. Recent investigations revealed a complex machinery of pro-
and anti-apoptotic protein factors the balance of which determine the difference between 
life and death (Raghupathi et al., 2000). The effect of the brain injury on the expression 
patterns of survival promoting-proteins, such as Bcl-2, Bcl-xL and the extracellular-signal 
regulated kinase (ERK), or the death-inducing proteins and lipids, such as Bax, ceramide, c-
Jun N-terminal kinase (JNK) and the caspase family of proteases have been documented 
(Ariga et al., 1999; Li and Yuan, 1999; Schwartz and Baron, 1999; Sastry and Rao, 2000). 
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Neuroligands 
The research discussed in this dissertation has been focused on the short and long-
term effect(s) of the neuroligands ATP, stromal cell-derived factor 1 a (SDF-la) and 
cannabinoids on neural cells, primarily astrocytes. We assayed changes in the [Ca2+]j, 
glutamate release and cell viability elicited by the neuroligands. 
ATP The functional importance of intracellular ATP levels for the cellular metabolism has 
been recognized for many years. Recent investigations postulated a new role for ATP in 
modulation of neurotransmission, cardiac function and other biological processes 
(Burstock, 1990; Gordon, 1986). It has been documented that ATP is released or co-
released with acetylcholine and norepinephrine from nerves endings (Fyffe and Perl, 1984; 
Bumstock 1986). It has been suggested that ATP might also be an excitatory mediator in 
the CNS (Phillis and Wu, 1981). There are two classes of purinergic receptors (Bumstock 
1990). One is the adenosine-sensitive Pl-purinoreceptor, and the other is the ATP-sensitive 
P2-purinoreceptor. Activation of P2 receptors leads to an increase in [Ca2+]i in a variety of 
excitable and unexcitable cells (El-Moatassim et al., 1992; Jahromi et al., 1992; Salter and 
Hicks, 1994). Two different mechanisms regulate the ATP-induced calcium transients. One 
involves the direct activation of the ionotropic family of P2Xi_7 receptors (Benham and 
Tsien, 1987). The other involves the activation of the metabotropic family of P2Ym , 
receptors (Boyer et al., 1989). The P2Y receptor family is coupled to Gq/i i proteins by 
which ATP induces activation of phospholipase C (PLC) and the subsequent breakdown of 
phosphoinositides (Pearce et al., 1989). 
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Cannabinoids The major psychoactive component of marijuana and its natural source 
plant, Cannabis sativa, is the ^-^-tetrahydrocannabinol (THC). So far, two cannabinoid 
receptors have been cloned and characterized, CBi and CBz. Radioligand binding studies 
confirmed the presence of CBi receptors in the brain (Axelrod et al., 1998), where they 
modulate adenylate cyclase and ion channel activity via Gy0 protein regulation (Tao and 
Abood, 1998). CB% receptors are found in the cells of the immune system and are also 
coupled to Gj/o proteins (Axelrod and Felder, 1998). 
Arachidonylethanolamide (anandamide) was the first discovered endogenous ligand of 
CBi receptors (Devane et al., 1992). It mimics the pharmacological effects of THC. Studies 
showed that the synthesis and release of anandamide could be stimulated in cortical and 
stratial neurons, but not astrocytes, by the application of membrane-depolarizing agents 
such as ionomycin and high potassium (Di Marzo et al., 1994). Neurons and astrocytes 
were both found to re-uptake anandamide rapidly (Deutsch and Chin, 1993) by the 
saturable, selective, temperature-dependent and Na+-independent transporter, whose 
inhibition potentiates anandamide action (Beltramo et al., 1997). Recently, potent 
exogenous cannabinoid receptor agonists (Win 55,212-2; HU-210; CP-55940) that share 
similar pharmacological and physiological properties with the endogenous cannabinoid 
receptor ligands, have been synthesized (Felder et al., 1995). 
In the nervous system cannabinoids exert most of their action through the specific 
interaction with abundant CBi receptors in neurons of specific brain regions (Pertwee et al., 
1997). Cadogan (1997) showed that ananadamide inhibits forskolin-stimulated cAMP 
formation in striatial slices. In hippocampal neurons, anandamide inhibits presynaptic N 
and P/Q type Ca2+ channels leading to the inhibition of transmitter release (Twitchell et al., 
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1997). Anandamide stimulates arachidonic acid (AA) release from primary cultures of rat 
brain cortical astrocytes (Shivachar et al., 1996). Similarly, THC induces AA release from 
cultured hippocampal neurons (Chan et al., 1998). Furthermore, THC induces a delayed 
increase of [Ca2+]j in primary hippocampal neurons (Chan et al., 1998). Cannabinoids effect 
on Ca2+ transients is also indirect as the R(+)-methanandamide enhances NMDA-elicited 
Ca2+ signals in cerebellar granule neurons through action at the CBi receptor (Netzeband et 
al., 1999). Cannabinoids also act on astrocytes by a non-cannabinoid receptor mechanism. 
The Venance's group (1995) found that anandamide blocked the propagation of astrocyte's 
Ca2+ waves evoked by glutamate released from neurons through the inhibition of gap 
junctions. 
SDF-la and gpl20 Chemokines, a large family of low molecular mass (8-10 kDa) 
cytokines, and their receptors are involved in cell migration during inflammation, in the 
establishment of the functional microenvironment and in organogenesis. They have been 
classified on the basis of the sequence of arranged cysteine groups into four subsets of 
chemokines reported to date: C, CC, CXC, and CX3C (Rollins et al., 1997). Most of the 
chemokines discovered to date belong to two major subfamilies: CXC (a-chemokines) or 
CC (^-chemokines). Chemokine receptors are members of the seven-transmembrane 
domain G-protein-coupled receptors (Bokoch, 1995). Chemokine receptors also act as co-
receptors for entry of different HIV-1 strains into lymphocytes and macrophages. CCR5 has 
been shown to function as a co-receptor for macrophage-tropic HIV-1 strains (Alkhatib et 
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al., 1996), whereas CXCR4 act as a co-receptor for T cell-tropic HIV-1 strains (Bleui et al., 
1996). 
Although most chemokine receptors bind several chemokines, CXCR1 and CXCR4 
are specific for only one physiological ligand. CXCR1 interacts with interleukin-8 (IL-8), 
whereas SDF-la is the only ligand identified so far for CXCR4 (Baggiolini et al., 1997). In 
contrast, the CC receptor subfamily interacts with the ^-chemokines group: monocyte 
chemoattractant protein-1 (MCP-1), -1, -3, -4, macrophage-inflammatory protein-la (MIP-
la) and RANTES. This group mainly attracts monocytes, whereas SDF-la is a neutrophil 
chemoattractant. 
The activation signals after SDF-la stimulation are not well defined and various 
signal transduction pathways have been implicated through the association of CXCR4 
receptor with G-proteins. Bajeto's group (1999) first showed that the CXCR4 receptor and 
its ligand SDF-la are expressed in cultured cortical type I astrocytes. The same group 
demonstrated the ability of SDF-la to increase [Ca2+], in cortical astrocytes and neurons 
and to inhibit cyclic AMP formation induced by forskolin treatment. It has been shown that 
SDF-la and gpl20 induce activation of extracellular signal regulated kinases (ERK) in 
astrocytes and neurons (Lazarini et al., 2000; Bezzi et al., 2001). ERK activation is the 
neurotoxic or neuroprotective. Furthermore, SDF-la triggers CXCR4 receptor dimerization 
and activation of JAK / STAT pathway similar to the action of other cytokines (Vila-Coro 
et al., 1999). 
HIV-1 viral products, implicated in neurotoxicity, include the proteins involved in viral 
replication: Tat, Nef and Rev, as well as envelope glycoproteins, gpl20 and gp41 
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(Nath et al., 1998). Lip ton* s group (1991) has reported the first evidence that gpl20 
neurotoxicity was mediated by NMDA-receptor activation. Subsequent studies, 
incorporating a variety of complementary experimental approaches, provided additional 
evidence that gpl20 has neurotoxic properties (Muller et al., 1992; Giulian et al., 1993; 
Yeung et al., 1995). gpl20 appears to cause neurotoxicity indirectly following interactions 
with cells such as microglia and astrocytes (Lipton et al., 1994). In neurons, gpl20 
increases [Ca2+]j by causing an influx of calcium through voltage- and receptor- operated 
calcium channels and release of calcium from intracellular pools (Dreyer et al., 1990). 
Many of the gpl20 neurotoxic actions appear to be mediated through interactions with glia 
because, in glial cells, gpl20 down regulates the production and release of endogenous 
neurotrophic substances and cytokines (Bagetta et al., 1996; Kong et al., 1996), inhibits 
glutamate uptake (Dreyer et al., 1995), and increases NaVH+ exchange, K+ conductance and 
tyrosine kinase activity (Benos et al., 1994; Bernardo et al., 1994; Bubien et al., 1995). 
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CHAPTER 2. ATP STIMULATES CALCIUM-DEPENDENT 
GLUTAMATE RELEASE FROM CULTURED ASTROCYTES 
A paper published in the Journal of Neurochemistry 
by 
Aleksandar Jeremic, Ksenija Jeftinija, Jelena Stevanovich, Aleksandra Glavaski and Srdija 
Jeftinija 
Abstract 
ATP caused a dose-dependent, receptor-mediated increase in release of glutamate and 
aspartate from cultured astrocytes. Using calcium imaging in combination with HPLC, we 
found that increase in intracellular calcium coincided with increase in release of glutamate 
and aspartate. Competitive antagonists of P2 receptors produced a block of the response to 
ATP. The increase in intracellular calcium and release of glutamate evoked by ATP were 
not abolished in low Ca2+-EGTA saline, suggesting involvement of intracellular calcium 
stores. Pretreatment of the glial cultures with an intracellular Ca2+ chelator abolished the 
stimulatory effects of ATP. Thapsigargin (l^iM), an inhibitor of Ca2+-ATPase of the Ca2+ 
pump of internal stores, significantly reduced the calcium transients and the release of 
aspartate and glutamate evoked by ATP. U73122 (10 pM), a phospholipase C inhibitor, 
attenuated the ATP-stimulatory effect on calcium transients and blocked ATP-evoked 
glutamate release in astrocytes. Replacement of extracellular sodium with choline failed to 
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influence ATP-induced glutamate release. Furthermore, the inhibitor of the glutamate 
transporters p-chloromercuri-phenylsulfonic acid and L-rra/zs-pyrolidine-2,4-dicarboxylate 
failed to impair the ability of ATP to stimulate glutamate release from astrocytes. However, 
an anion transport inhibitor, furosemide, and potent CI "channel blocker, 5-nitro-2(3-
phenylpropylamino)-benzoate, reduced ATP-induced glutamate release. These results 
suggest that ATP stimulates EAA release from astrocytes through a calcium-dependent 
anion-transport sensitive mechanism. 
Key words: astrocyte-neuron signaling, calcium transients, glutamate, purinergic 
receptors, transmitter release. 
Introduction 
Bumstock first showed in 1976 that extracellular adenosine 5-triphosphate (ATP) can 
influence neurotransmission, cardiac function, muscle contraction and other biological 
processes, raising the issue that ATP can function as transmitter. It has been shown that 
ATP can be released or co-released with acetylcholine or norepinephrine from nerve 
endings (Fyffe and Perl, 1984; Bumstock, 1986). Extracellular ATP excites a subpopulation 
of rat dorsal horn neuron (Jahr and Jessel, 1983) and rat sensory neurons (Krishtal et al., 
1988). It was also reported that ATP depolarized cultured hippocampal neurons and 
induced release of glutamate from the neurons (Inoue et al., 1992). The actions of ATP are 
mediated by Pz-purinoceptors which are present on many cell types including neurons and 
astrocytes (Phillis and Wu, 1981; Salter and Henry, 1985; Pearce et al., 1989). There is 
evidence that activation of Pz-purinoceptors leads to an increase in intracellular calcium in a 
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variety of excitable and unexcitable cells (O'Connor et al., 1991). Two mechanisms are 
involved in ATP-evoked intracellular calcium increase. First, ATP can activate 
nonselective cation channels, resulting in depolarization and subsequent opening of 
voltage-dependent Ca2+ channels ( Friel, 1988). The increased calcium influx is also the 
result of direct activation of ATP-gated cation channels (Benham and Tsien 1987). Second, 
the extracellular ATP can stimulate the breakdown of inositol phospholipids and the 
resulting increase in inositol 1,4,5,-triphosphate (IP3) is responsible in part for the elevation 
of cytosolic Ca2+ (Danziger et al., 1988). 
There is an increasing body of evidence showing that neuroglia may be more 
actively involved in brain function than has been previously thought. It has been 
demonstrated that neuroglia have multiple roles in the nervous system which include the 
regulation of extracellular potassium, the uptake of excitatory amino acids (EAAs) and the 
release of neurotransmitter such as glutamate, aspartate and acetylcholine (Nicholls and 
Atwell, 1990; Barres, 1991; Kanai et al., 1993; Smith, 1994). Recent work from our 
laboratory shows that the release of the excitatory neurotransmitter glutamate from 
astroglial cells plays a key role in glia-neuron signaling (Parpura et al., 1994, Jeftinija et al., 
1996). 
Although it has been determined that extracellular ATP can stimulate Ca2+ influx 
and increase intracellular calcium in cultured astrocytes (Neary et al., 1991; Salter and 
Hicks, 1994), the consequences of induced calcium elevations in glia are unknown. Our 
previous study shows that the neuroligand bradykinin can induce the release of EAAs from 
cultured astrocytes in a Ca2+-dependent manner (Parpura et al.; 1994; Jeftinija et al., 1996). 
Furthermore, we demonstrated that ATP induced glutamate release from cultured Schwann 
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cells (Jeftinija et al., 1998). This evidence prompted us to propose that extracellular ATP 
might influence the functions of astrocytes. In this study, we demonstrate that ATP can 
evoke release of EAAs from cultured astrocytes and that intracellular Ca2+ plays a role in 
the release of EAAs. 
Material and Methods 
Cell Culture 
Mixed cell cultures from neonatal rat cerebral cortex were established according to the 
previously described procedure (Jeftinija et al., 1996). Briefly, cortex was freshly dissected 
and tissue was enzymatically (papain 20i.u./ml; lhour at 37°C) and mechanically 
dissociated. The cells were plated into culture flasks and maintained at 37°C in a 
humidified 5% COz/95% air atmosphere. Culture medium consisted of Eagle's MEM 
supplemented with 19% heat-inactivated FBS and 40mM glucose, 2mM L-glutamine and 
gentomicin. 
The enriched astrocyte type-1 cultures were obtained by following the protocol 
previously described (Jeftinija et al., 1996). After mixed cultures reach confluence (9-12 
days), the flasks were "preshaken" (260rpm) for 90min to remove microglia and dividing 
type I astroglia. Following preshake, the medium was replaced, and the flasks were 
incubated for 1 hour to equilibrate. The cultures were then shaken overnight (12-18h) at 
260 rpm at 37°C. After this two sets of cells were present: adherent polygonal cells (mostly 
type I astroglia) and suspended cells. Cultures enriched in type I astroglia were obtained by 
trypsinising (0.25%) for 5 min the cells attached after the overnight shake. Trypsin was 
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inactivated by adding 5 ml of serum-supplemented BME (serum contains protease 
inhibitors) to each flask. Then the cell suspension was transferred to sterile 50-ml centrifuge 
tubes and spun at 100-x g for 10 min. Cells were resuspended in a-MEM and the number of 
viable cells was determined by trypan blue exclusion. Cells were plated on poly-L-lysine 
(lmg/ml; MW 100,000)-coated glass coverslips. The cells were maintained by completely 
changing the a—MEM medium every 2-3 days. All experiments were performed on cells 
that have been in culture for 3-5 days after re-platting. 
The protocol used for acutely isolated astrocytes is a modification of procedure used 
for establishing the primary astrocyte cultures. Tissue from cortex or hippocampus were 
incubated with 2.5 % papain solution for 50 min. at 37° C. After the incubation tissue was 
mechanically dispersed by triturating through a fire-polished glass pipette 8-10 times and 
plated on the poly-L-lysine (lmg/ml, MW 100,000; Sigma) coated glass-bottomed dishes. 
Cells were incubated for 20 minutes at 37°C to allow them to adhere. A further 1-ml of a-
MEM solution was added to each dish. The time from killing of the animal to the final 
addition of a-MEM and beginning of experiments were 1-2 hours. No obvious cell 
divisions were detected within 48 hours and cultures were considered to be acute cell 
cultures. 
Immunocytochemistry (ICC): 
Antibody visualization was accomplished by using a Vectastain ABC kit (Vector) and the 
nickel-enhanced DAB method (Jeftinija and Jeftinija., 1990). ICC was performed using 
antibodies raised against glial fibrillary acidic protein (GFAP; 1:5000, ICN 
Immunobiological) and the microtubule associated protein, MAP-2 (1:2000, Boehringer). 
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Staining was performed by exposing cultures to 0.04% 3-3'diaminobenzidine 
tetrahydrochloride (DAB, Sigma), 2.5% nickel sulfate (Fisher Scientific) and 0.01% 
hydrogen peroxide dissolved in 0.1 M sodium acetate. Controls were processed by omitting 
the specific antiserum. 
Release methods and HPLC 
The coverslips with glial cultures were mounted into a perfusion chamber and washed in 
normal HEPES saline for a period of 30 to 40 min to allow equilibration. Normal HEPES 
saline contains (in mM): NaCl 140, KC1 5, MgCU 2, CaClz 2, glucose 5 and HEPES 10 (pH 
7.4). The volume of the chamber was about 50 p.1. Standard and test solutions were pumped 
into the perfusing system by a minipuls pump at a rate of200|a.l/min. After equilibration, 
200 fil samples were collected every minute. Four control samples were collected for 
determination of basal concentrations of amino acids. Test substances were dissolved in the 
recording solution and delivered in known concentrations to the cultures. The amino acid 
content in the samples was determined by high-performance liquid chromatography 
(HPLC) with fluorescence detection. Prior to injection, aliquots of the samples were 
derivatized with o-phthalaldehyde (OPA) 2-mercaptoethanol reagent (Pierce). 
Chromatography was performed on a 15cm Microsorb-MV HPLC column (Rainin 
Instrument Co.) using a pH 5.9 sodium acetate methanol gradient. Basal rates of amino 
acids released were determined as the mean of the amino acids in 4 samples collected just 
prior to stimulation. In the experiments in which calcium was lowered to 0.2mM, Mg2+ 
was elevated to 2.5mM and ImM EGTA was added. 
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Intracellular calcium imaging 
The effect of experimental manipulation on glial [Ca2+]j was evaluated by fluorescence ratio 
imaging technique. Cells were loaded with 5 (iM Fura-2 AM (Molecular Probes) for 40-60 
minutes at 24°C. lfil of 25% (w/w) of Pluronic F-127 (Molecular Probes) was mixed with 
every 4 nmol of Fura-2 AM to help dissolving of the ester into aqueous medium. After 
washing, cells were deesterified for 10 minutes at 24°C. All image processing and analysis 
were performed using an Attofluor system with Zeiss microscope. Background subtracted, 
rationed images (340/380 nm) were used to calculate the [Ca2+]j according to Equation 5 of 
Grynkiewicz et al. (1985). Calibration was performed in situ according the procedure 
provided by the Attofluor, using the Fura-2 Penta K+ salt as a standard. 
Results 
Morphology of cultured astrocytes 
Phase-contrast microscopy indicated that glial cultures were enriched in type-1 astrocytes 
devoid of neurons. This was confirmed by immunocytochemistry which demonstrated that 
cultures lacked MAP-2 immunoreactivity but were more than 95% immunopositive for 
glial fibrillary acidic protein (GFAP). In parallel mixed cortical cultures containing 
neurons, MAP-2 immunoreactivity was reliably detected. Therefore, enriched astrocyte 
cultures in the current study were considered neuron-free and the predominant cell type in 
these cultures was GFAP-positive polygonal astrocyte type 1. 
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ATP evokes receptor-mediated release of glutamate from cultured astrocytes type I 
The release of glutamate from primary glial cultures was assayed using HPLC on 
the superfusate. The basal release of aspartate and glutamate in to the superfusate produced 
levels of 25 ± 3 nM and 58 ±4 nM, respectively (mean + SEM, n=12). Addition of ATP 
caused a concentration-dependent increase in release of excitatory amino acids (EAA) from 
astrocyte cultures. The threshold concentration of ATP was 1 pM (data not shown). 
Perfusion application of 10 pM ATP for 2 min increased the concentration of aspartate and 
glutamate from 24 ± 5 nM to 38 ± 7 nM and from 54 ± 9 nM to 84 ± 13 nM, respectively 
(mean ± SEM, n-6). Perfusion application of 100 pM ATP for 2min to astrocyte culture 
resulted in a 212 +.10 % increase of glutamate concentration and 407 ± 21 % increase of 
aspartate concentration (n=6, Fig. 1 A). A second application of ATP 10 min after the first 
application resulted in an increase in the release of glutamate and aspartate that was at the 
level of 64% of that produced by the first application (Fig. 1 A). A ten-minute application 
of ATP to astrocytes resulted in a peak increase in the release of glutamate followed by a 
decline to a plateau that was significantly higher than baseline release (p<0.001, Student's 
t-test, n=6, Fig. IB). 
To investigate the type of purinergic receptors in cultured astrocytes the effects of 
adenosine were examined. Adenosine had no effect on release of glutamate from cultured 
astrocytes (data not shown). These results indicate that the ATP response is mediated by P2 
receptors. Suramin at a concentration of 100 pM produced a block of the response to ATP 
(n=6; P0.001, Student's t-test, Fig. 1C). Suramin, a trypanocidal drug, is a competitive 
Figure 1. Stimulatory effect of ATP on EAAs release from astroglia is receptor-mediated. 
The superfusate from astrocyte cultures was collected at one-minute intervals and levels of 
EAAs were measured using HPLC. (A) Addition of ATP (100 p.m) for 2 min causes a two­
fold increase of glutamate concentration and fourfold increase of aspartate concentration 
from baseline levels. Repeated application of ATP ten minutes later produced an increase in 
EAA concentrations that were ~60% of the first application (B) Ten minutes application of 
ATP resulted in a twofold increase of glutamate concentration followed by sustained 
declining release of glutamate that was significantly higher than the control release. (C) 
Suramin (100 pM), the Pz receptor antagonist abolished the ATP-evoked glutamate release 
from actrocyte cultures. 
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antagonist at P% receptors (Dunn and Blakeley, 1988; Hoiting et al., 1990). The blockade of 
ATP-induced glutamate release by suramin was reversible (Fig. 1C). Similar results were 
obtained with pyridoxal-phosphate-6-azophenyl-2\4'-disulphonic acid tetrasodium 
(PPADS), a selective P% antagonist (data not shown). 
ATP mobilizes calcium in cultured astrocytes type I 
To ask whether calcium might play a role in ATP-induced EAA release from cultured 
astrocytes, we used a fluorescence calcium imaging technique to monitor glial calcium 
levels. Cells were loaded with the membrane permeant calcium indicator fura-2 AM. In 
resting conditions, the cytoplasmic calcium level of glia was 91 ±2 nM (n=201). ATP (10 
JJ.M) raised the cytoplasmic level of free calcium in 97 % of cells tested (n=194 of 201). 
This increase of intracellular calcium reached the peak level of207 + 7 nM (n=189; Fig. 
2A) about 80 seconds after the onset of ATP application and was sustained for several 
minutes. Repeated applications of ATP elevated calcium levels in astrocytes (Fig. 2A). 
The Pz receptor antagonist PPADS (50 pM) reversibly attenuated the stimulatory action of 
ATP on calcium mobilization. In the presence of the PPADS, the average resting calcium 
level of 92 + 4 nM was increased by application of lOpM ATP to 114 + 5 nM (n=74). 
However, after washout of the antagonist, ATP increased the cytoplasmic calcium level 
toi 79 + 5 nM (n=74), a value significantly greater than in the presence of the P2 receptor 
antagonists (pO.OOl, ANOVA followed by Tukey'spost hoc test, Fig. 2B). Similar results 
were obtained with suramin (Fig.2C). The effect of suramin was selective, as effect of 
bradykinin was not influenced by application of suramin (Fig. 2C). 
Figure 2. ATP-induced calcium transients requires activation of the P2 receptor. Perfusion 
application of 10 ATP for 1 min reliably raised intracellular calcium in primary 
astrocyte cultures (A). PPADS (50 |iM), a selective P% receptor antagonist reversibly 
attenuated the ATP stimulatory action on [Ca2+], in astrocytes (B). Pz receptor involvement 
was further supported with 100 fiM suramin, another Pz receptor antagonist that selectively 
blocked the ATP but not bradykinin evoked calcium transients' (C). 
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Removal of external calcium from the batheing medium did not prevent the initial 
calcium mobilizing action of ATP. Cells were bathed in a calcium-depleted saline 
containing 0.2 mM calcium with the addition of 1 mM EGTA to yield an estimated free 
extracellular calcium level of 26 nM. We found that it was necessary to have some calcium 
in the bathing medium otherwise cells detached from the culture substrate. In this calcium-
depleted saline, ATP elevated cytoplasm free calcium from 96 + 2 nM to 210 + 6 nM 
(n=121, Fig.3A). However, subsequent additions of ATP in calcium-depleted bathing 
medium had little calcium mobilizing action (n=26) and (n=18) for the second and third 
applications, respectively (Fig. 3A). These data suggest that ATP mobilize calcium from 
internal stores and that these stores must refill with calcium from the extracellular medium. 
To evaluate contribution of internal calcium stores in ATP stimulatory effect on 
cultured astrocytes we used [1,2-bis (2-aminophenoxy) ethane-N,N,N',N'-tetracetic acid-
acetoxymethyl ester] (B APT A-AM), an intracellular calcium chelator. Cultures pre-
incubated in 50 pM B APT A-AM for 45 min did not respond to 10 pM ATP application 
(n=87, Fig. 3B). Calcium mobilization from an internal store is further supported by 
observations using thapsigargin, an inhibitor of the Ca2 -ATPase of internal calcium stores 
(Thastrup, 1990). Following the first application of ATP, thapsigargin (50 nM) was added 
to the culture to prevent reloading of internal stores with calcium. Addition of thapsigargin 
alone caused a significant increase in calcium from 120 + 3 to 178 + 5 nM (n=38; Student t-
test, p<0.0001, Fig. 3C). In the presence of thapsigargin, a second application of ATP 
failed to mobilize internal calcium (n=38; Fig. 3C) as compared to matched control cells 
Figure 3. ATP mobilizes calcium from internal calcium stores. (A) The ATP stimulatory 
effect on calcium transients in astrocytes was preserved in low calcium solution suggesting 
that calcium is mobilized from internal stores. However, second and third addition of ATP 
had little effect on internal calcium levels. (B) BAPTA-AM (50 pM), a cell permeable 
intracellular calcium chelator abolished the ATP evoked calcium transients. (C). 
Thapsigargin (50 nM), a Ca2+-ATPase inhibitor completely blocked the increase in calcium 
induced by ATP application. (D) U73122 (10 pM), a specific PLC inhibitor attenuated the 
ATP-stimulatory effect on calcium transients suggesting the involvement of PLC-IP3 
pathway. U73122 completely blocked the ATP stimulatory action only in the low Ca2+ 
solution pointing toward the contribution of ionotropic P% system and the extracellular 
calcium in the ATP-evoked calcium transients (E). In acute cultures, U73122 completely 
blocked the ATP stimulatory effect implying that cells possess only metabotropic P2 PLC-
coupled receptors (F). 
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which were incubated in the DMSO carrier saline, supporting the notion that ATP 
mobilizes calcium from an internal store. 
To determine the type of internal calcium store that ATP acts on, we added 
ryanodine, caffeine-sensitive calcium store inhibitor. Ryanodine (10 (iM) did not affect the 
calcium mobilizing action of repeated applications of ATP (data not shown). Furthermore, 
the sustained presence of caffeine (20 mM) did not alter the ATP stimulatory effect in 
astrocytes (data not shown). Thus, we conclude that ATP predominantly mobilizes calcium 
from an ryanodine/caffeine-insensitive internal calcium store. This suggests that ATP's 
actions are mediated through an IP3- sensitive calcium store. 
ATP-induced calcium transient is blocked by U73122 
To examined the role of IPs-sensitive calcium stores in ATP-evoked calcium transients we 
used U73122, a selective inhibitor of receptor-coupled phospholipase C (PLC) dependent 
processes (Smith, 1990). The effect of U73122 on the ATP-evoked calcium transients in 
astrocytes depended on the age of the culture. In primary astrocyte cultures (cells cultured 
for 12-15 days) the ATP-induced response was significantly smaller in cultures pretreated 
with 10 pM U73122 (n=86, p<0.01, ANOVA followed by Tukey s post hoc test Fig. 3D). 
However, completely block of ATP-induced response in cultured astrocytes was achieved 
only in the low Ca2+-EGTA solution combined with U73122 (10 pM) pretreatment (n=l 13, 
Fig. 3E). These results are indicating presence of both ionotropic and metabotropic 
component of ATP response in cultured astrocytes and by using Pax receptor antibodies we 
determined the presence of both P2X2 and P2X3 receptors (data not shown). However, 
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response of the acutely isolated astrocytes (less than 48 hours in culture) to ATP was 
completely abolished by preincubation of the cells with 10 pM U73122, indicating presence 
of metabotropic Pz receptor only (n=43, Fig. 3F). In order to identify neurons in acutely 
isolated cells, we took advantage of the observation that neurons respond promptly with a 
[Ca2+]j increase to depolarization induced by 50 mM K+ (Bezzi et al., 1998). Perfusion 
application of 50mM K was without effect (Fig. 3F). Culturing of the cells leads to 
expression of the Pz ionotropic receptors which is in agreement with the studies showing 
different receptor expression patterns for acutely isolated astrocytes and cell in cultures 
(Kimelberg et al., 1997). 
ATP induced release of glutamate does not depend on extracellular Ca2+ 
Calcium-imaging data demonstrated that ATP induced increase in intracellular calcium 
does not depend on extracellular Ca2+. To investigate whether calcium might play a role in 
ATP-induced EAAs release from astrocyte cultures, cells were bathed in a calcium-depleted 
saline containing 0.2 mM calcium with the addition of 1 mM EGTA to yield an estimated 
free extracellular calcium level of 26 nM. Consistent with the ability of ATP to mobilize 
intracellular calcium, the first ATP application stimulated the release of glutamate from 
glial cultures in calcium-depleted saline (n=6, Fig. 4A). The second ATP application failed 
to evoke glutamate release from cultures bathed in low Ca2+ solution but not in the control 
(Fig. 4A). This observation suggests that ATP-induced release of glutamate is not 
dependent on extracellular Ca2+ and therefore likely results from calcium release from 
intracellular stores. 
Figure 4. Extracellular calcium is not necessary for ATP-evoked glutamate release from 
cultured astrocytes. (A) An increase in glutamate concentration in glia cell perfusate by the 
100 pM ATP application was not altered when cultures were bathed in low Ca2+-EGTA 
solution. (B) In cultures incubated in 50 pM B APT A-AM for 30 min the ATP stimulatory 
effect was abolished. (C) A 30-min incubation of astrocytes in 1 pM thapsigargin resulted 
in an increase in the baseline concentrations of glutamate and block of ATP-evoked 
increase in glutamate concentration. (D) A specific PLC inhibitor U73122 (10 pM) 
diminished the ATP-evoked glutamate release from astrocytes. 
glutamate concentration (nM) glutamate concentration (nM) glutamate concentration (nM) glutamate concentration (nM) 
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In order to confirm that calcium is involved in glutamate release, we pretreated 
cultures with 50 pM B APT A-AM, the membrane permeable Ca2+ chelator, for 30 min. The 
baseline level of glutamate was significantly elevated in superfusate from cultures exposed 
to B APT A-AM (P<0.05, Student's t-test, n=6, Fig. 4B) while ATP-induced release of 
glutamate was abolished (n=6, Fig. 4B). This result suggests that intracellular Ca2+ might be 
responsible for ATP-induced release of glutamate. 
Involvement of an internal Ca2+ store in the ATP-evoked calcium mobilization and 
subsequent glutamate release were further supported in experiments using thapsigargin, a 
potent inhibitor of the Ca2+-ATPase of the endoplasmic reticulum (Thastrup, 1990). Addition 
of thapsigargin (1 pM) alone raised glutamate baseline above the control glutamate 
concentrations (P<0.05, Student s t-test, n=6, Fig. 4C). In the presence of thapsigargin, ATP 
failed to produce a change in glutamate concentration supporting the notion that ATP mobilizes 
calcium from an internal store (Fig. 4C). To determine the type of internal calcium store that 
ATP acts on, we added ryanodine, caffeine-sensitive calcium store inhibitor. Ryanodine (10 
pM) did not affect the ATP-evoked increase in glutamate. Furthermore, the sustained presence 
of caffeine (20 mM) did not affect stimulatory action of ATP (data not shown). This suggests 
that ATP's actions are mediated through an IP3-sensitive calcium store. 
To investigate the role of IPs-sensitive calcium store in ATP-evoked increase in 
intracellular Ca2+ and corresponding release of glutamate from cultured astrocytes we used 
PLC inhibitor U73122. Following the first application of ATP (lOOpM) cultures were 
perfused with 5 jaM U73122 solution for 10 min. We found that U73122 (5PM) had no 
effect on basal levels of glutamate (n=6). In the presence of U73122, a second application 
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of ATP failed to produce a change in glutamate concentration (n=6, Fig. 4D) supporting the 
notion that ATP mobilizes calcium from an IPs-sensitive calcium store. This is consistent 
with other studies, which have shown that ATP causes a phosphatidylinositol hydrolysis in 
oligodendrocytes and astrocytes (Pearce et al., 1989). 
Inhibitor of glutamate uptake does not affect ATP-induced release of glutamate 
Extracellular glutamate accumulation may be caused by inhibition of the uptake or 
reversal of the Na+-dependent glutamate transporter (Szatkowski et al., 1990). To examine 
the relationship between ATP-induced glutamate release and activity of Na+-dependent 
glutamate transporter, we preincubated cultures in Na+-free medium. In Na+-free medium 
extracellular NaCl was substituted with choline chloride. ATP-evoked release of glutamate 
or [Ca2+]i was not influenced by pretreatment of the cultures with Na+-free medium (n=4, 
Fig 5A). These results suggest that ATP-induced glutamate release from cultured astrocytes 
is not Na+-dependent. 
To determine whether membrane potential might regulate [Ca2+]j and glutamate release 
from astrocytes, we exposed astrocyte cultures to high potassium saline. Following 
application of 50 mM K+ saline for 2 min we detected no increase in [Ca2+]j and change of 
glutamate concentration (data not shown). 
The possible role of glutamate transporters as mediators of ATP-induced glutamate 
release was further investigated using glutamate transport inhibitors p-chloromercuri-
phenylsulfonic acid (p-CMPS) and L-rra/is-pyrolidine-2,4-dicarboxylate (PDC) (Balcar and 
Johnston, 1972; Balcar et al., 1987; Isaacson and Nicoll, 1993). Consistent with previous 
Figure 5. ATP-induced glutamate release from primary astrocyte cultures is not mediated 
by transporter mechanism. (A) In cultures incubated in Na+-free medium, neither baseline 
nor ATP-evoked release of EAA was influenced by treatment. The glutamate transporter 
inhibitors p-CMPS (50 pM) and PDC (ImM) elevated the baseline concentration of 
glutamate but failed to block the stimulatory action of ATP on glutamate release (B and C) 
glutamate concentration (nM) glutamate concentration (nM) glutamate concentration (nM) 
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observations, p-CMPS (50|aM) and PDC (ImM) produced an increase in the baseline 
concentration of glutamate in the perfusate (Fig. 5B and C). Both p-CAMP and PDC failed 
to impair the ability of ATP to stimulate glutamate release from astrocytes (pcO.OOl, 
Student's t-test, n=4, Fig. 5B and C). 
As we have previously shown that bradykinin-evoked release of glutamate from 
astrocyte cells is sensitive to the anion co-transport inhibitor furosemide (Parpura et al., 
1994; Jeftinija et al., 1996), we determined whether ATP-induced release of EAA from 
astrocytes has a similar sensitivity by incubating cultures in furosemide (5 mM). As 
illustrated in Figure 6 A, ATP-induced release of glutamate was reduced in the presence of 
furosemide (n=5). In the presence of 5-nitro-2(3-phenylpropylamino)-benzoate (NPPB, 
lOO^iM), a potent CI channel blocker in concentrations of <10pM ( Wangemann et al., 
1986; Diener and Rummel, 1989) and anion co-transport inhibitor in higher concentrations 
(Petersen and Cormann, 1987), the stimulatory effect of ATP on the release of glutamate 
was abolished in cultures pretreated with lOOpM NPPB (n=4, Fig. 6B). NPPB in 
concentration of lOfaM was without effect (data not shown). These data provide 
additionally support for the possibility that ATP-induced glutamate release from cultured 
astrocytes is sensitive to the anion transport inhibitors. 
Role of ATP in neuron-to-glia signaling 
To study possible role of ATP in neuron-glia interaction we determined whether 
ATP released by neurons acts on glial cells and further we determined whether glutamate 
released by ATP from glial cells is acting on neurons. Both of these experiments were 
Figure 6. ATP-induced glutamate release from primary astrocyte cultures is sensitive to 
anion co-transport inhibitor and CV channel blocker. (A) Bath application of 5 mM 
furosemide, an anion co-transporter inhibitor, attenuated the stimulatory effect of ATP on 
glutamate release from cultured astrocytes. (B) In the presence of NPPB (lOOpM), a potent 
CI" channels blocker, the stimulatory effect of ATP on the release of glutamate was 
abolished. 
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performed in mixed neuron-glia cultures. In order to identify neurons in mixed neuron-glia 
cultures, we took advantage of the observation that neurons responded promptly with a 
[Ca2+]j increase to depolarization induced by 50 mM K+ (Bezzi et al., 1998). To explore 
whether potassium-induced released ATP from neurons act on astrocytes to elevate 
calcium, we added suramin, a selective P% receptor antagonist. Suramin (100 jaM) 
abolished the potassium-induced stimulatory effect in about 30% of astrocytes in mixed 
cultures (n=12 of 37, Fig. 7A/ Washing the cultures for 10min reversed the suramin effect 
(Fig. 7A). 
To see whether ATP-induced glutamate released from astrocytes acts on neurons, 
we studied the effect of ATP on [Ca2+]i, in neurons co-cultured with astrocytes. When 10 
|iM ATP was applied, calcium levels increased significantly in astrocytes (n = 46) and 
neurons (n = 26) after 15 and 50 sec, respectively (Fig. 7B). To determine whether ATP 
acts directly on neurons to elevate neuronal calcium levels or acts indirectly through 
glutamate released from astrocytes, we added 2-amino-5-phosphonopentanoic acid (D-
AP5), a potent specific NMDA receptor antagonist. D-AP5 (25 fiM) abolished the 
ATP-induced calcium elevation in about 45% of neurons cultured with astrocytes (n=12 of 
26), without altering the astrocyte response to ATP (Fig. 7B). These data suggest that ATP 
may elevate neuronal calcium indirectly by the action of glutamate, which is released from 
astrocytes in response to ATP. 
Figure 7. ATP is a mediator of neuron to glia signaling (A) Bath application of 50 mM 
potassium directly stimulated changes in [Ca2+] ; in neuron and indirectly in glia in a mixed 
neuron-glia culture. Stimulatory effect of high potassium on astrocytes was abolished by 
suramin application. Horizontal bars indicate onset and duration of perfusion application of 
the compounds. The delay in the onset of the effect is due to the dead space of the 
perfusion system. (B) Stimulatory effect of ATP on neurons in the neuron-glia co-cultures 
is indirect one. Chart illustrates calcium changes in a neuron and two adjacent glia cells 
following application of 50mM K+, 1 mM NMDA and 10 pM ATP prior to and during the 
application of 25 ^M D-AP5, a specific NMDA antagonist. Response of the neuron to 
NMDA and ATP was abolished in the presence of D-AP5. 
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Discussion 
Our data demonstrate that the release from astrocytes of the excitatory amino acids, 
glutamate and aspartate, is induced by the neuroligand ATP. ATP caused the mobilization 
of calcium from internal stores in astrocytes within seconds of addition to cultures. This 
calcium elevation is sustained for several minutes. ATP releases glutamate and aspartate 
within one minute of delivery of ATP to the perfusion chamber. Thus, the ATP-induced 
calcium elevation is temporally coincident with the release of EAAs raising the possibility 
that it is required for EAA release. When calcium mobilization was blocked using BAPTA-
AM or by removing external calcium during repeated ATP applications, ATP no longer 
stimulated the release of EAAs from astrocytes. Taken together these data demonstrate that 
ATP mobilizes internal calcium in astrocytes, which is both necessary and sufficient to 
stimulate the release of glutamate and aspartate. 
A key issue to address is the nature of the release mechanism that is responsible for 
EAA liberation from astrocytes (Attwell, 1994; Smith 1994). This release mechanism may 
take at least three forms. Glutamate can be released through the reversal of a glutamate 
transporter. Both astrocytes and retinal Muller cells have been shown to release glutamate 
in a calcium-independent fashion in response to elevated [K+]e due to the reversal of the 
normal glutamate uptake mechanism (Rutledge and Kimelberg, 1996; Szwatkovski et al., 
1990). This mechanism probably does not account for the release of EAAs in response to 
ATP in cortical astrocytes, since the action of ATP is calcium-dependent, glutamate release 
is not stimulated by depolarizing stimuli which would reverse the glutamate uptake carrier 
and p-CMPS and PDC do not block ATP-induced release of glutamate. 
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In cortical astrocytes hyposmotic medium causes cell swelling and the consequent 
release of glutamate, taurine and aspartate (Kimelberg et al., 1990; O'Connor and 
Kimelberg, 1993). An anion transport blocker, furosemide, reduces cell swelling 
dependent release from cortical astrocytes (Kimelberg et al., 1990). This raises the 
possibility that ATP may cause cell swelling which in turn stimulates EAA release from 
astrocytes. We therefore tested the action of furosemide on ATP-induced glutamate 
release. In astrocytes furosemide reduced ATP-stimulated glutamate release. In the 
presence of NPPB, a potent CI" channels in lower concentration and inhibitor of CI /HCO3, 
in higher concentration, the stimulatory effect of ATP on the release of glutamate was 
abolished only when anion transport-blocking concentrations of NPPB were used. These 
data provide additionally support for the possibility that ATP-induced glutamate release 
from cultured astrocytes is sensitive to the anion transport inhibitors. 
A third potential mechanism of ATP-stimulated EAA release is through a 
membrane/vesicle release mechanism similar to that of neurons. Previously we have shown 
that some elements of the secretosome are present in the cultured astrocytes and that 
clostridial toxins influence neuroligand induced EAA release from cultured astrocytes 
(Jeftinija, 1997). Absence of some of the elements of secretory machinery does not rule 
out quantal membrane release mechanisms since muscle (Dan and Poo, 1992) and 
fibroblasts (Morimoto et al., 1995) have been demonstrated competent to release 
neurotransmitters in a quantal fashion. The nature of this calcium-dependent release 
apparatus from astrocytes remains to be defined. Bafilomycin, a V-ATPase inhibitor that 
dissipates the electrochemical proton gradient necessary for glutamate uptake in vesicles 
(Maycox et al., 1988), reduced the ability of astrocytes to release glutamate (Araque et al., 
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2000), further supporting the hypothesis that vesicle exocytosis mediates glutamate release. 
Our finding that there are certain [Ca2+]i changes that do not result in glutamate release 
from astrocytes suggests that certain [Ca2+]i threshold should be reached for glutamate 
release. Recently it has been demonstrated that the calcium-regulated release of glutamate 
from astrocytes is engaged at physiological calcium levels (Parpura and Haydon, 2000). 
The regulated release of neurotransmitters from glia may be a widespread property. 
Stimulation of motoneurons leads to the elevation of calcium in the Schwann cells that 
surround the presynaptic terminal (Jahromi et al., 1992). After denervation, Schwann cells 
have been shown capable of releasing acetylcholine (Dennis and Miledi, 1974). 
Depolarization of hippocampal astrocytes causes the calcium-dependent release of the 
amino acid taurine, but not glutamate (Philibert et al., 1988). Recently, we demonstrated 
that glial cells from the cerebral cortex release aspartate and glutamate in response to 
bradykinin (Parpura et al., 1994, Jeftinija et al., 1996). Since many neurotransmitters 
utilized by the nervous system can mobilize calcium in glia (Cornell-Bell et al., 1990; 
Glaum et al., 1990; Charles et al., 1991; Cornell-Bell and Finkbeiner, 1991; McCarthy and 
Salm, 1991), it is possible that neurons have in addition to their fast neuron-neuron synaptic 
actions, a calcium mobilizing action on neighboring glia (Dani et al., 1992) which in turn 
leads to the release of other neurotransmitters from glia that may serve secondary roles in 
glia-neuronal transmission. In support of this possibility recent studies have demonstrated 
that glia can signal to neurons (Nedergaard, 1994; Parpura et al., 1994). 
The specific roles for release of excitatory amino acids from glial cells remains to be 
elucidated. It has been demonstrated that ATP is a compound of the extracellular 
communication between astrocytes (Guthrie et al., 1999). The experiments reported here 
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demonstrate that neurons release a compound that is stimulatory to astrocytes and is 
blocked by selective purinergic receptor antagonists. This finding suggests a role for ATP 
as an effective compound of the neuron to astrocyte signaling. The release experiments 
reported here demonstrate that astrocytes release glutamate in response to ATP. Previously, 
Queiroz et al. (1997) reported that ATP release from astrocytes could be evoked by 
glutamate receptor activation. Therefore, there is a potential for formation of a positive 
feed-back loop between release of glutamate and ATP by astrocytes. Finally, our results 
with mixed cultures demonstrate that stimulatory effects of ATP on neurons are in part 
blocked by NMDA receptor antagonists suggesting an indirect effect through the astrocytes. 
Given the important role of glutamate in the induction of long-term potentiation, it 
will be important to determine whether glia regulate synaptic plasticity, learning and 
memory by releasing the neurotransmitter glutamate and whether excessive glutamate 
release from glia also contributes to neurodegenerative disorders. 
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CHAPTER 3. CANNABINOID-INDUCED ASTROTOXICITY 
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Abstract 
Astrocytes account for more than half of the cells in the human brain and recently it has 
been shown that astrocytes integrate neuronal input and modulate synaptic transmission. 
The role of astrocytes in the pathophysiology of the brain, however, has been less 
investigated. Here we, for the first time, show that ^-tetrahydrocannabinol (THC), a 
psychoactive component of marijuana, produces a receptor-mediated stimulation of 
astrocytes and induces injury. Furthermore, using fluorescent dyes we show that astrocytes 
undergo apoptosis in response to cannabinoids. These data demonstrate a previously 
unknown property for astrocytes in the induction of cannabinoid-mediated astrotoxicity, 
suggesting that neurotoxicity may be initiated by nonneuronal signals and raising the 
possibility that astrocytes may actively participate in the neurotoxicity of cannabinoids. 
Key Words: astrocytes, THC, calcium, apoptosis 
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Introduction 
Marijuana, a widely used drug of abuse, has a long history of consumption for recreational 
and medical reasons. Marijuana is used therapeutically for several conditions, including 
treatment of pain and inflammation, nausea caused by AIDS and cancer chemotherapy and 
muscle spasms associated with multiple sclerosis (Adams and Martin, 1996; Hollister, 
1986; Jaffe, 1990). The mayor psychoactive component of marijuana and its natural source 
plant Cannabis sativa is the A-9-tetrahydrocannabinol (THC). In humans, psychoactive 
cannabinoids elicit a variety of responses, like: euphoria, enhancement of sensory 
perception, antinociception, difficulties in concentration and impairment of memory that 
persist after withdrawal. 
Two different cannabinoid receptors CB| and CB] have been found. Radioligand 
binding studies confirmed the presence of CBi receptors in the brain (Devane et al., 1988), 
where they modulate adenylate cyclase and ion channels activity via Gi/0 protein regulation 
(Tao and Abood, 1998). CBz receptors are predominantly found in the cells of the immune 
system (Felder and Glass, 1998). Astrocytes express the mRNA's for CBi receptor 
determined by the Northern blot (Bouaboula et al., 1995a) and the CBi receptor determined 
by the Western blot (Sanchez et al., 1998a). 
Although it is known that cannabinoids cause a reduction in neuron density in rodent's 
hippocampus (Landfïeld et al., 1988) and impair spatial memory in rats (Lichtman et al., 
1995), marijuana toxicity has been underestimated. Only recently, a study showed that 
THC is toxic to cultured hippocampal neurons (Chan et al., 1998). It is known that prenatal 
exposure to THC affects gene expression and the activity of tyrosine hydroxylase during 
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early brain development (Hernandez et al., 1997). Although suggested, the role of 
astrocytes in the pathology of the nervous system has been difficult to study because 
astrocytes respond to an insult by cell division and repopulate the damaged area, forming 
glial scares. 
In this study, we took advantage of methods to isolate astrocytes type I and then to 
culture them in a defined serum-free medium to regulate astrocyte proliferation. In light of 
new evidence which emphasises glia as a key player in the control of synapse formation 
and possible memory formation (Ullian et al., 2001), we undertaken a study to evaluate the 
deleterious effect of cannabinoids on astrocytes. 
Materials and Methods 
Cell cultures 
Mixed neuron-glia and primary astrocyte cultures from neonatal rat cerebral cortex were 
established as described (Jeremic et al., 2001). Briefly, cortex was freshly dissected and 
tissue was enzymatically (papain 20 i.u./ml; lhour at 37°C) and mechanically dissociated. 
Cells were plated on poly-L-lysine (1 mg/ml; MW 100,000)-coated glass cover slips (for 
mixed cultures) or culture flasks and maintained at 37°C in a humidified 5% COz/95% air 
atmosphere (for primary astrocyte cultures). The cells were maintained by changing the 
medium every 2-3 days. Culture medium consisted of Eagle's MEM supplemented with 
10% heat-inactivated FBS and 40 mM glucose, 2 mM L-glutamine and gentamicin. After 
the mixed cultures reached confluence (9-12 days), the flasks were "preshaken" (260 rpm) 
for 90 min to remove microglia and dividing type I astroglia. The cultures were then 
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shaken overnight (12-18 hours) at 260 rpm at 37°C. Cultures enriched in type I astroglia 
were obtained by trypsinizing (0.25%) the attached cells for 3 min. Trypsin was inactivated 
by adding 3 ml of Eagle's aMEM supplemented with the 10% heat-inactivated FBS (serum 
contains protease inhibitors). Astrocytes were plated on the poly-L-lysine (10 ng/ml; MW 
100,000)-coated glass cover slips. All experiments were performed on cells that had been 
in culture for 3-5 days after replating. 
Organotypic cultures of brain slices were prepared as described (Gahwiler, 1981). 
Briefly, hippocampal slices of 250 |im were obtained from 2 weeks old Sprague-Dawleye 
rats. Acutely isolated slices were transferred to glass cover slips coated with chicken 
plasma that was coagulated by thrombin. Glass cover slips with the expiant were placed 
into Petri dishes and were fed with the medium (25% horse serum, 25% Earls Balanced 
Salt Solution, 50% Basal Medium Eagles with glucose 6.4 mg/ml). Petri dishes were kept 
in an incubator at 36°C in 95% air and 5% COz 
Ca2 imaging 
The effect of experimental manipulation on glial [Ca2+]j was evaluated by fluorescence 
ratio imaging technique. Cells were loaded with 5 pM Fura-2 AM (Molecular Probes) for 
40-60 minutes at 24°C. 1 fil of 25% (w/w) of Pluronic F-127 (Molecular Probes) was 
mixed with every 4 nM of Fura-2 AM to help dissolving of the ester into aqueous medium. 
After washing, cells were deesterified for 10 min at 24°C. All image processing and 
analysis were performed using an Attofluor system with Zeiss microscope. Background 
subtracted, rationed images (340/380 nm) were used to calculate the [Ca2+]j according to 
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Equation 5 of Grynkiewicz et al. (1985). Calibration was performed in situ according to the 
procedure provided by the Attofluor, using the Fura-2 Penta K+ salt as a standard. 
Toxicity assay. Astrocyte cultures were plated on 24-well plates and maintained in serum-
containing medium for 2-3 days. 24 hours before applying treatments, serum-containing 
media were replaced with serum-free QBSF-51 media (Sigma). In this media, astrocytes 
persist without a detectable change in astrocyte viability for at least 72 hours. Appropriate 
cannabinoid dilutions were made in absolute ethanol and a 500nM-l|xM concentrations of 
THC and WIN were added to cultured astrocytes for indicated periods of time. Vehicle in 
0.1% concentration had no significant effect on the cell viability. At the end of incubation 
MTT was added to the QBSF-51 media (250 ng/ml) and incubated for 3 hours at 37° C. 
After incubation, the medium was removed and an insoluble formazan dye was solubilized 
with isopropanol/HCl solution. The absorbency of the converted dye was measured at 570 
nm with background subtraction at 630 nm. 
Fluorescent staining protocol 
AnnexinV-FITC staining protocol: primary astrocyte cultures were incubated with 5 jiM 
dye diluted in Hepes-buffer solution (in mM: NaCl 140, KC15, MgClz 2, CaCh 2, glucose 
5 and HEPES 10; pH 7.4) for 15 min in the dark. Cultures were mounted in the perfusion 
chamber and examined with a Zeiss epifluorescence microscope using FITC filter set. 
Images were collected with a Nikon Coolpix digital camera and the fluorescence signal 
quantified with MetaMorph imaging software. Acridine orange/propidium iodide staining 
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protocol: 30 min before AO/PI staining, the cultures were incubated with 10 ng/ml RNase 
A at 25° C. Additionally, cultures were incubated for 10 minutes in the dark with AO (5 
fj.M) and PI (2.5 |iM). Primary astrocyte cultures were washed twice in Hepes buffer 
solution and the cells were visualized under epifluorescence illumination: AO (480 nm for 
excitation and 510 nm barrier filter for emission); PI (540 nm and 610 nm excitation-
emission filter set), with 40X oil immersion objective. The percentage of apoptotic cells 
was scored from each field and determinations were made in at least four separate cultures. 
The percentage of apoptotic cells was determined by nuclear morphology examination: 
cells with condensed and/or fragmented DNA were considered apoptotic, while the nuclei 
with diffusely and uniformly DNA distributions were considered as nonapoptotic. 
A similar protocol was used for the determination of apoptotic astrocytes in mixed 
neuron-glia cultures. Prior to AO staining, mixed cultures were fixed in 4% formaldehyde 
for 30 min, permeabilized in solution containing: 0.5 % Triton X-100, 1 % BSA and 1 % 
horse serum for 25 min. Then, the cultures were incubated with monoclonal Anti-GIial 
Fibrillary Acidic Protein-Cy3 conjugated antibody (1: 200 dilution; Sigma, St. Louis, MO) 
for 4 hours at 25° C for astrocyte visualization. 
For morphological analysis of apoptotic nuclei in organotypic cultures, cultures 
were prepared as described (Gahwiler, 1981). We implemented the same AO/antiGFAP-
Cy3 staining protocol as for the mixed neuron-glia cultures. Images were obtained with the 
Leica confocal laser scanning microscope, using FITC filter set (excitation: 480 nm; 
emission: 520 nm) for AO staining and Cy3 filter set (excitation: 540 nm; emission: 610 
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nm). The same nuclear morphological criterion was used for apoptotic cell determination 
as was applied for the apoptotic nucleus determination in the primary astrocyte cultures. 
Results 
Cannabinoids induce receptor-mediated biphasic calcium transients in astrocytes 
Cover slips containing enriched astrocyte type I cells were mounted into a fast rate 
exchange perfusion chamber for imaging experiments (Jeremic et al., 2001). Using Fura-2 
AM calcium imaging to examine the stimulatory effects of cannabinoids in astrocytes we 
determined that cannabinoids produced a biphasic calcium response. Perfusion application 
of Win 55,212-2 (WIN 10 pM), a stable cannabinoid receptor agonist, for 10 min produced 
an increase in intracellular calcium, followed by return to the control level, and followed by 
a delayed and irreversible increase in intracellular calcium (n=34; Fig. 1 A). 
^-tetrahydrocannabinol (THC 10 pM), an active component of marijuana, elicited 
a similar pattern of calcium transients in astrocytes but with slower kinetics of the delayed 
increase (n=36; Fig. 1 A). The recovery of the cultures from cannabinoid insult was not 
detected within the duration of the recording of 5000 sec. In addition, disappearance of the 
cell images was observed suggesting irreversible damage of membrane integrity and 
leakage of Fura-2 dye (Fig. IB). A selective CB, receptor antagonist SR141716A (Rinaldi-
Carmona et al., 1994), abolished the THC- induced calcium transients in astrocytes, 
suggesting that cannabinoids stimulate astrocytes via CB,-receptor activation (n=32; Fig. 
1C). Two different calcium pools contributed to the cannabinoids-induced biphasic 
response in astrocytes. Low extracellular Ca2+ did not affect the initial component of WIN-
Fig. 1. Cannabinoids induce biphasic calcium transients in the primary astrocyte cultures 
by a receptor-mediated mechanism. (A) Graph illustrates kinetics of calcium changes in 
astrocytes following the cannabinoid application. Perfusion application of the 10 |xM THC 
induced a rapid increase in intracellular Ca2+ followed by recovery and by a delayed 
irreversible increase in intracellular Ca2* (A). A more potent cannabinoid receptor agonist 
10 pM WIN produced a greater response when applied for 10 min only (A, Bb). (B) 
Pseudocolour images (a-d) of the WIN-induced calcium transients in astrocytes are 
captured at the time marked on the graph (A). Scale bar, 25p.m. (C) Stimulatory effect of 
THC was abolished by pretreatment of the culture with the CBi-receptor antagonist, 
SR141716A (5|nM). (D and E) The rapid response of cells to cannabinoids (WIN 10 |xM) 
was preserved in cells bathed in low calcium medium, while the delayed response was 
abolished in the absence of extracellular calcium. Replenishment of extracellular calcium 
resulted in a rapid increase in the intracellular calcium (D). Elimination of the extracellular 
calcium at the time of peak response to WIN resulted in an abrupt decrease in the response 
(E). (F) While the cannabinoid-induced rapid increase in intracellular calcium is abolished 
in cultures pretreated with thapsigargin (lOOnM), the delayed response was unaffected by 
thapsigargin pretreatment. (G) Both responses to cannabinoids were attenuated by the 
application of a PLC inhibitor. In the presence of U73122 (lOpM), a rapid response to 
WIN was decreased by 56 ± 6 % while the kinetics of the delayed response was slower. 
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induced change in intracellular calcium while the delayed response was abolished (n=37; 
Fig. ID and E). Pretreatment of cells with thapsigargin, a Ca2+"ATP-ase inhibitor 
(Thastrup et al., 1990), blocked the cannabinoid-induced rapid increase in calcium while 
the delayed response was unaffected (n=41; Fig. IF). These results suggest that the 
observed early increase in intracellular calcium induced by cannabinoids originated from 
the intracellular stores, while the irreversible calcium increase results from an extracellular 
calcium entry. Both responses to WIN application were attenuated in the presence of 
U73122, a phospholipase C (PLC) inhibitor (Smith et al., 1990), which confirms the role of 
receptor-coupled PLC dependent processes in the cannabinoid-induced calcium transients 
in astrocytes (n=45; Fig. 1G). 
Cannabinoid-induced dose-dependent decrease in astrocyte viability is CBi receptor 
mediated 
To determine the possible toxic effect of cannabinoids on the astrocytes as 
suggested by the Ca2+ imaging experiments (Fig. IB), we employed MTT assay as a 
measure of cell viability (Hansen et al., 1989). Concentrations of WIN and THC as low as 1 
were toxic to primary cortical astrocytes (n=8; Fig. 2A and B). This concentration is 
comparable to the THC-concentrations found in human plasma after consumption of a 
single marijuana cigarette (Chiang and Bamett, 1984). Cannabinoid-induced decrease in 
the cell viability was time- and concentration-dependent (Fig. 2A-C). Time course 
experiments showed that continuous application of 10 nM THC induced a significant 
decrease in cell viability 3 hours after treatment and a maximum of 90 % of the control 
after 6 hours (n=8; Fig. 2C). As concentrations of cannabinoids decreased, the time to 
Fig. 2. Cannabinoid receptor ligand-induced astrotoxicity is a dose- and time-dependent. 
(A and B) Continuous application of 10 |iM WIN and THC induced a 90 % decrease in 
cell viability after 6 hours. In concentration of 5 pM, WIN and THC produced a 50 % 
decrease in astrocyte viability within 6 hours and a 90% decrease within 24 hours. As 
concentrations of cannabinoids decreased to 2.5 pM, no detectable decrease in cell viability 
was determined within the first 6 hours, but an 80-90 % decrease was recorded after 36 
hours. At threshold concentration of 1 pM, both THC and WIN induced a measurable 
decrease in cell viability after 24 hours exposure and the maximum decrease in astrocyte 
viability by 20 % was detected after 48 hours. (C) To determine the onset and early course 
of the THC toxicity, astrocyte cultures were exposed to 5 and 10 gM THC in duration 1 to 
6 hours, with the initial cannabinoid toxicity detected at 3 hours. (D) To determine the 
prolonged effect of short exposure to cannabinoids, cells were incubated with 10 fJ.M THC 
for 30-120 min, followed by removal of the agonist and reincubation in the conditioned 
media for an additional 12 hours. Exposure of the astrocytes to 10 pM THC for 30 min 
resulted in a detectable damage in cells viability 12 hours later. (E and F) The cytotoxicity 
of cannabinoids on astrocyte cultures is reversible. To investigate the ability of astrocyte 
cultures to recover following a toxic insult, cultures were exposed to 2.5 THC for 24 
hours that resulted in a 60 % decrease in cell viability. Replacement of the THC-containing 
medium with the cell growth-promoting medium resulted in a recovery of the cultures to 
the control level (E and F). Panels (E) illustrate the phase contrast micrography of 
astrocyte cultures obtained at the times indicated on the time course line of the histogram 
(F). Scale bar, 50*iM. 
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produce a detectable decrease in the cell viability was prolonged. At a threshold 
concentration of 1 p.M both THC and WIN induced a measurable decrease in viability after 
24 hours exposure (n=8; Fig. 2A and B). To determine the prolonged effect of short 
exposure to cannabinoids, THC was applied for 30-120 min at the concentration of 10 jxM 
and the cell viability was determined 12 hours later. We observed that even 30 min 
incubation with THC was enough to initiate astrocyte death 12 hours later (n=6; Fig. 2D). 
The ability of astrocytes to recover from the cannabinoid insult was determined. Exposure 
of cells to 2.5 jiM THC for 24 hours resulted in a 60 % decrease of astrocyte population 
(n=7; Fig. 2F). Replacement of the THC-containing medium with cell growth promoting 
medium resulted in recovery of the cultures to the control level (Fig. 2E and F). 
To determine the possible role of CBi receptor in the cytotoxicity of cannabinoids, 
we used SR141716A, a CB; receptor antagonist. SR141716A (5 |iM) abolished the THC-
and WIN-induced astrocytes death (n=8; Fig. 3B). In addition, bath application of 1 p.M 
and 2.5 jiM S(-) Win 55,212-3, a less active enantiomer of R(+)Win 55,212-2, had no 
significant effect on cell viability (p>0.1, n=8; Fig. 3A). 
Cannabinoids induce death of cortical astrocytes via primary and secondary effector 
enzyme activation 
To test the possibility that THC-induced astrotoxicity results from inhibition of 
adenylyl cyclase activity by the activation of a pertussis toxin (PTX)-sensitive G,y0 protein, 
we pre-treated cells with PTX (100 ng/ml) for 24 hours. PTX significantly protected cells 
against THC toxicity (p<0.01, n=8; Fig. 3C). In addition, our data suggested significant 
Fig. 3. Cannabinoid induced astrotoxicity is the CBi receptor-mediated. (A) While bath 
application of 1 jiM and 2.5 pM R(+)Win 55,212-2 (WIN-2) produced a significant 
decrease in cells viability (p<0.01, n=8), bath application of 1 jiM and 2.5 (J.M S(-)Win 
55,212-3 (WIN-3), had no significant effect on cell viability (pX).l, n=8). (B) A selective 
CBi receptor antagonist SR141716A (5 jiM) abolished the THC and WIN-induced 
astrotoxicity. (C) THC astrotoxicity is attributed to G-protein activation. Treatment of the 
cultures with 15 fiM mastoparan (Mas) resulted in decrease in cell viability to 35 ± 2 % 
(n=8). On the other hand 24 h pretreatment of cells with lOOng/ml pertussis toxin (PTX) 
and 5pM Ras farnesyltransferase inhibitor III peptide (FTI-3) protected the cultures against 
THC-induced astrotoxicity. (D) THC astrotoxicity is not attributed to the adenylyl cyclase-
cAMP second messenger system and it is not extracellular calcium dependent. 10|iM 
Forskolin (Fsk) and IOOjjM SQ22536 (SQ) did not significantly change the THC-induced 
toxicity (p>0.1, n=8). Maintenance of the astrocytes in the 3mM EGT A-supplemented 
serum-free medium or a loading the cells with lOpM B APT A-AM were without effect on 
the THC-induced decrease in astrocyte viability. 
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contribution of small G-proteins like Ras to the THC-induced cell death, since the FTI-3, a 
potent Ras farnesyltransferase inhibitor peptide, abrogated THC toxicity (Fig. 3C). These 
results, in conjunction with the ability of mastoparan to trigger cell death (Fig. 3C), 
emphasize an important role of the G-protein signaling system in the cannabinoid-induced 
astrotoxicity. In contrast, neither the fbrskolin, an adenylyl cyclase activator, nor 
SQ22536, an adenylyl cyclase inhibitor, showed any significant effect on the THC-
induced toxicity (p>0.1, n=8; Fig 3D). These results uncouple the link between adenylyl 
cyclase activity and the receptor-mediated THC-induced astrotoxicity. Incubation of the 
astrocyte cultures in the low calcium medium or loading the cells with B APT A-AM, an 
intracellular calcium chelator, did not rescue astrocytes from THC-induced cell death (Fig. 
3D). These results suggest that cannabinoids induce a calcium-independent cell death, and 
the irreversible calcium entry along with a disappearance of the cell images observed upon 
cannabinoids application (Fig. 1A and B) represent an outcome of cannabinoids toxicity 
rather than the death-signaling pathway employed by cannabinoids. 
It has been shown that cannabinoids could stimulate receptor mediated arachidonic 
acid (AA) release from cultured astrocytes (Shivachar et al., 1996). AA is the substrate for 
several major pathways. Cyclooxygenase (COX) produces prostaglandins and lipoxygenase 
produces leukotrienes. Both pathways generate free radicals (Yamamoto, 1991). The PLA% 
inhibitor, Quinacrine, and indomethacin, a COX inhibitor, blocked the THC-induced cell 
death in primary hippocampal neurons (Chan et al., 1998). However, both inhibitors failed 
to protect astrocytes against the toxic effect of THC (Fig. 4A), implying a different death-
signaling pathway for astrocytes and neurons. Nordihydroguaiaretic acid (NDGA), a 
Fig. 4 THC induces cell death via primary and secondary effector enzyme activation. (A) THC 
induced astrotoxicity is not attributed to the PLA2-Cyclooxygenase pathway. Incubation with 
0.5pM Quinacrine (Qui) and 5pM indomethacin (Ind) failed to protect astrocytes from the toxic 
effect of THC (p>0.05, n=8). 5jiM NDGA did not protect astrocytes as well. However 50 |iM 
LY294002 (LY), a specific PI3-kinase inhibitor, significantly protected astrocytes against THC-
induced astrotoxicity (p<0.001, n=7). (B) PLC and PKC inhibitors protected astrocytes against 
THC toxicity. 5 |iM U73122 (U73) attenuated the cell death evoked by the THC. 10 pM l-O-
Hexadecyl-2-O-acetyl-sn-glycerol (HAG), significantly protected astrocytes from THC-mediated 
toxicity (p<0.001, n=8). 5 pM Rottlerin (Rot) induced similar protective effect in astrocytes. 1,2-
DAG (2.5|iM), but not 1,3-D AG (2.5pM), triggered a significant decrease in cell viability (p<0.01, 
n=8). (C) THC-induced astrotoxicity is associated with ERK activation. While 20pM SB-203580 
(SB) did not have any significant effect on THC -induced astrotoxicity (p>0.05, n=8), 20|*M 
PD98059 (PD) antagonized the toxic effect of THC. Incubation of cells with 1 pg/ml actinomycin D 
(ActD) abrogates the THC-induced astrotoxicity. (D) De ziovo-synthesized ceramide has a 
significant role in THC-induced astrotoxicity. Incubation of cells either with 10 pM Desipramine 
(Dsp) or lpM 3-O-methyl-sphingomyelin (MSM), had no significant effect on the THC induced 
astrotoxicity (p>0.1, n=7). However, 2.5 mM L-Cycloserine (LCS), an inhibitor of ceramide 
biosynthesis, significantly protected cells from THC toxicity (pcO.OOl, n=8). (E) Antioxidants, 
Vitamin E (50 jaM), 250 pM ^-acetyl-cysteine (NAC) and antioxidants solution 5% B-27 
abrogated THC astrotoxicity. Z-Vad-FMK (50 pM), an inhibitor of caspases, protected astrocytes 
from the THC-induced cell death (p<0.01, n=8). (F) Cannabinoids induce astrocytes death through 
a hypothesized multiple signaling pathway. Activation of CB, receptor by cannabinoids induce a 
Gvo-protein subunits dissociation and activation of multiple downstream signaling pathways: a 
subunit of Gv0 could mediate ERK activation via a PI3K / Ras-independent pathway (Jordan et al., 
1999; Mochizuki et al., 1999), while the /%rdimer activates ERK trough the PI3K / Ras / Raf 
cascade. Alternatively, fiydxcaex may activate PLCp, which in turn stimulates DAG and IP3 
formation. IP3 triggers calcium release from intracellular stores while DAG activates a novel class 
of PKC s, that leads to apoptosis. In addition, cannabinoids induce caspases activation and de novo 
synthesis of ceramide that stimulates ROS overproduction. 
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selective lipoxygenase inhibitor, did not protect astrocytes as well (Fig. 4A). In contrast, 
LY294002, a specific phosphatidylinositol 3—kinase inhibitor (PI3K), blocked the THC-
induced astrocytes death (p<0.001, n=7; Fig. 4A). This result points to the possible 
activation of CB% receptor / Ras and Gy0/ PI3K / mitogen-activated protein kinase (MAP) 
signaling cascade in astrocytes elicited by cannabinoids. This was already observed as a 
primary signaling mechanism in the MAP cascade activation in other cells (Bouaboula et 
al., 1995b; Liu et al., 2000). As U73122, a selective inhibitor of PLC, abrogated calcium 
transient evoked by cannabinoids (Fig. 1G), we tested its ability to suppress cannabinoid-
induced astrotoxicity. U73122 attenuated the astrocytes death evoked by the THC 
(p<0.001, n=8; Fig. 4B). Furthermore, we observed a significant contribution of protein 
kinase C (PKC) to the cannabinoid-induced cell death as the 1 -O-Hexadecyl-2-O-acetyl-sn-
glycerol, an isotype-selective PKC inhibitor that inhibits PKC activation by diacylglycerols 
(Daniel et al., 1988), significantly protected astrocytes from the THC-mediated toxicity 
(pcO.OOl, n=4; Fig. 4B). In same manner Rottlerin, a specific PKCô inhibitor (Gschwendt 
et al., 1994), abrogated THC toxicity (p<0.001, n=4; Fig. 4B). A PKC-dependent cell death 
was further supported by the ability of 1 -Oleoyl-2-acetyl-sn-glyceroi, a potent membrane-
permeable DAG that activates PKC (Mori et al., 1982), to provoke cell death on its own 
(Fig. 4B). 
The link between PKC activation and MAP cascade activation is well established. 
MAP kinase mediate diverse processes ranging from transcription of protooncogenes to 
apoptosis (Cobb, 1999). Cannabinoids elicited MAP kinase activation in many cells 
including Ce glioma cell line and astrocytes (Galve-Roperh et al., 2000; Rueda et al., 2000; 
Sanchez et al., 1998b). These facts prompted us to evaluate the role of the MAP cascade in 
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these events. SB-203580, a selective inhibitor of p38 MAP kinase (Cuenda et al., 1995), 
did not have any significant effect on THC induced astrotoxicity (p>0.05, n=8; Fig. 4C). In 
contrast, a potent and selective inhibitor of extracellular signal-regulated kinase (ERK) 
cascade PD98059 (Dudley et al., 1995), was able to antagonize the toxic effect of THC on 
cultured astrocytes (p<0.001, n=8; Fig. 4C). Furthermore, actinomycin D, an inhibitor of 
transcription, significantly decreased THC-induced astrotoxicity (pO.OOl, n=8; Fig. 4C), 
which suggests that THC may activate a transcription-dependent cell death. 
An activation of the CBi receptor in astrocytes led to sphingomyelin hydrolysis and 
ceramide formation that stimulated glucose metabolism (Sanchez et al., 1998b). To 
determine a possible ceramide involvement in the initiation of apoptotic events in 
astrocytes by cannabinoids, we employed inhibitors of the ceramide generation pathways. 
Neither Desipramine, an acidic SM-ase inhibitor, nor 3-0-methyl-sphingomyelin, an 
inhibitor of neutral SM-ase, showed any significant protection of astrocytes against THC 
toxicity (p>0.05, n=8; Fig. 4D). However, L-Cycloserine, an inhibitor of serine palmitoyl 
transferase (Sundaram and Lev, 1984), the first committed step of ceramide synthesis de 
novo, significantly protected astrocytes from THC (pcO.OOl, n=8; Fig 4D). This result 
emphasizes a ceramide synthesis pathway as an important factor in the THC-induced 
apoptosis in astrocytes rather than ceramide generation through sphingomyelin hydrolysis. 
There is mounting evidence to support a role of oxidative stress and reactive oxygen 
species (ROS) as important players in the chain of reaction leading to cell death. We 
examined the effect of the antioxidants, vitamins E and N-acetyl-cysteine, on the THC-
induced astrocyte death. Both substances abrogated the cytotoxicity of THC (Fig. 4E). The 
full protection of cells against THC toxicity was achieved with the strong antioxidant 
solution B-27 (Gibco) that contains mixture of five antioxidants: vitamin E and C, 
glutathione, superoxide dismutase and catalase (Brewer et al., 1993), thus supporting a role 
of free radicals on these processes (Fig. 4E). More importantly, Z-Vad-FMK, a cell 
permeable, broad spectrum caspase inhibitor, protected astrocytes from THC-induced cell 
death (p<0.01, n=8; Fig. 4E). 
Cannabinoids induce apoptosis in astrocytes 
To discriminate between the types of cell death induced by cannabinoids 
fluorescent probes were used. Treatment of cultured primary astrocytes from rats with 
cannabinoids led to apoptotic body formation (panel b; Fig. 2E). AnnexinV-FITC 
conjugate is a phospholipid binding protein with high affinity for phosphatidylserine (PS). 
Externalization of PS is one of the earliest indicators of apoptosis. We observed a 
significant increase in the fluorescence intensity in cells treated with cannabinoids 
compared with control cells (p<0.001, n=4; Fig. 5A-C). 
Acridine orange and propidium iodide fluorescent dyes discriminate between 
apoptotic and necrotic cell death. Acridine orange intercalates into double-stranded (intact) 
DNA emitting the green fluorescence, whereas when bound to single-stranded DNA or 
RNA, it fluoresces red (Darzynkiewicz et al., 1992). In the presence of RNase, cells 
fluoresce green (Fig. 5G) or a yellow in the absence of RNase due to the green-red spectra 
overlap (Fig. 5D), indicating viable cells. In addition to the increase in the amount of PS on 
the cell membrane, the early (6 hours) cannabinoid-induced apoptotic stage in astrocytes 
has been characterized by an increase in the RNA content as well. A change in RNA 
content was revealed by the marked shift in the fluorescence emission signal from a yellow 
to an orange-red spectrum due to the increase in red fluorescence (Fig. 5D and E). Similar 
determination of cell's DNA and RNA contents using acridine orange staining has been 
recently employed (Vidotto et al., 1996). An increase in the RNA content in the early stage 
of apoptosis of astrocytes observed by fluorescent staining may be relevant to cannabinoid 
toxicity since we showed that THC activates a transcription-dependent cell death (Fig. 4C). 
The late apoptotic stage, 12 hours of the cannabinoid-induced cell death in primary 
astrocyte cultures, was characterized by a marked decrease in the cell body size and by a 
large increase in the number of cells with a condensed nucleus 76/124 (61 %) versus 
controls 7/147 (5 %) (n=4; Fig. 5G and H). Low PI fluorescence suggests that there is very 
limited necrosis in the 12 hour period (Fig. 51). Apoptotic features similar to those that 
cannabinoids induced in a primary astrocyte cultures, were observed in the mixed neuron-
glia cultures (Fig. 5M) and in the short-time (24 to 48 hours) cultured organotypic slices 
(Fig. 5R). This preparation recapitulates the types of cells normally found in the brain, i.e., 
neurons, astrocytes, microglia and macrophages. 
Discussion 
Cannabinoids induced a biphasic calcium response in cultured astrocytes. Initial, 
rapid increase in [Ca2+]j was followed by decline to the control level and then by a steady 
and sustained increase. Both phases were CBi -receptor dependent and mediated by the 
PLC. The rapid component of the cannabinoid-induced calcium response originated from 
the intracellular calcium stores, while the delayed and sustained calcium increase resulted 
from the calcium influx. The sustained calcium elevation induced by the cannabinoids was 
Fig. 5. Cannabinoids induce apoptosis in primary astrocyte, mixed neuron-glia and organotypic 
hippocampal cultures. (A-C) Fluorescent images of AnnexinV-FITC labeled cells, as early marker 
of apoptotic events in astrocytes, elicited by cannabinoids. Exposure of primary astrocyte cultures 
to 5pM WTN (B) and 5pM THC (C) for 6 hours resulted in 235 ± 12 and 258 ± 21 % increase in 
fluorescent intensity, respectively. (D-I) Cannabinoids induce nuclear condensation and increase 
in RNA content in astrocytes. Nuclear morphology was examined in enriched astrocyte cultures 
that were exposed to 5 jiM WIN (6 hours) and 5 fiM THC (12 hours) prior to 15-min exposure of 
cell-permanent DNA dye acridine orange (panel AO) and cell-nonpermanent DNA dye propidium 
iodide (panel PI). Cells were incubated with the nucleic acid dyes in the absence of RNase (D-F) 
and in the presence of RNase (G-I). Acridine orange intercalates into double-stranded DNA 
emitting the green fluorescent light (G). Nuclei that are stained with acridine orange in the absence 
of RNase emit yellow light due to the green and red fluorescence emission spectrum overlap (D). 
When the AO is bound to a single-stranded DNA or RNA, a fluorescent emission maximum of the 
dye is shifted to red spectra (Darzynkiewicz et al., 1992). In cells where the RNA content was not 
affected by the RNase treatment, cannabinoid-induced apoptosis was accompanied by an increase 
in RNA as revealed by the fluorescence emission shift toward the orange-red spectra (E). Cells 
exposed to the 5 pM THC for 12h in the presence of RNase exhibit a marked decrease in cell body 
size compared with untreated cells and the loss of green fluorescence due to nuclear condensation 
which indicated a late apoptotic stage of cannabinoid-induced cell death. Arrows indicate 
representative examples of condensed chromatin (H). Propidium iodide can not permeate live cells, 
but stains necrotic cells with red fluorescence. Low fluorescence in PI panels illustrates very 
limited necrosis during a period of 12 hours (F and I). (J-O) THC induces apoptosis of astrocytes 
in mixed glia-neuron cultures. By combining AO staining and anti-GFAP-Cy3 conjugated 
antibody fluorescent staining, we visualized astrocytes in control conditions (J-L) and following the 
exposure to 5 pM THC for 12 hours (M-O). Short arrows indicate representative examples of 
condensed chromatin of GFAP-positive cells, while long arrows indicate representative examples 
of condensed chromatin of other brain cells (M). (P-S) THC induces apoptosis of astrocytes in 
hippocampal organotypic cultures. We performed double staining to visualize GFAP-positive cells 
and to score apoptotic astrocytes. THC (5 pM, 12hours) induce chromatin condensation in 
astrocytes indicated by short arrows and in other brain cells indicated by long arrows (R). Scale 
bars, 25 nm. 
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accompanied with the disappearance of astrocytes from the visual field at the end of the 
calcium-imaging experiment, suggesting cannabinoid toxicity. We verified this assumption 
by the toxicity assay. Our results for the first time point to the toxic effects of cannabinoids 
on astrocytes, in both in vitro and in situ studies. In addition, we observed an ability of 
astrocytes to recover from the cannabinoid toxicity. The ability of astrocytes to repopulate 
might be of relevance to the pathology of the nervous system. It was documented that 
astrocytes respond to an insult by cell division and repopulate damaged area forming glial 
scares, a hallmark of many neurodegenerative changes in the brain (Raivich et al., 1999). 
The CBi receptor is coupled to the Gi/0 protein the activation of which modulates 
adenylate cyclase activity and cAMP levels. Survival of many cells depends on optimal 
cAMP levels (Holcomb et al., 1995). As expected PTX blocked cannabinoid toxicity. In 
addition, Ras peptide inhibitor abrogated THC toxicity, pointing to a major contribution of 
small G proteins in the mechanism of death. However, modulators of adenylyl cyclase 
activity had no significant effect on the cannabinoid toxicity, thus uncoupling the link 
between enzyme activity and cannabinoid toxicity. 
Gj/o protein activation is the signal for the activation of many downstream signal 
transduction pathways, PLC and MAP cascade among others. PLC activation leads to 
generation of inositol-3-phospates (IP3) and diacylglycerols (DAG). DAG can activate 
PKC, which in turn can phosphorylate and thus activate channels, transcription factors like 
AP I and / or MAP cascade that can lead to apoptotic and non-apoptotic cell death in many 
cells including neural cells (Mohr et al., 1998; Murray et al., 1998). Two different PKC 
inhibitors were able to suppress THC-induced cell death, emphasizing the possible 
activation of a novel class of PKC s, calcium-independent isozymes, rather than the 
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activation of calcium-dependent conventional PKC isozymes. This agrees with the 
observed calcium-independent mechanism of cannabinoid-induced cell death. Contribution 
of DAG and DAG responsive PKC s in the THC-induced astrocyte death was further 
supported by the ability of membrane-permeable DAG that activates PKC to provoke cell 
death on its own. 
Members of the ERK family are implicated in the cannabinoids toxicity because the 
selective ERK inhibitor, PD 098059. abrogated THC-induced cell death. In contrast, p38 
MAP kinase inhibitor failed to protect astrocytes. It is known that ERK activation induces a 
proliferation of cells that depends on the duration of the stimulus (Marshall, 1998). 
However, recent investigations point to another role of the ERK cascade in the cell's fate, 
since the activation of ERK induced death of the hippocampal neurons (Murray et al., 
1998) and astrocytes (Blazquez et al., 2000). A sustained ERK activation elicited by the 
THC induced apoptosis in C6 glioma cells in culture (Galve-Roperh et al., 2000). There 
are at least three different pathways that may activate ERK. (1) Activation of ERK cascade 
by a and Py-subunits released from heterotrimeric Gj and G0-proteins (Luttrell et al., 1999; 
Mochizuki et al., 1999) and ERK activation by small G-proteins such as Ras (Fruman et al., 
1998); (2) activation of ERK cascade by the calcium-independent PKC isoforms (Neary et 
al., 1999); (3) activation of ERK cascade by the ceramide-activated Raf-1 (Sanchez et al., 
1998b). 
Our results suggest that THC activates a CBi / Gi/C / PI3K / Ras / ERK signaling 
cascade in astrocytes. We postulated a signaling pathway in which the CBi receptor 
activation induces G-protein subunits dissociation and subsequent Py subunits-mediated 
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PI3-kinase activation. Additionally, we observed a significant contribution of small G-
proteins like Ras, the activation of which is mediated by PI3K (Fruman et al., 1998). Ras 
activation initiates Raf-1 protein kinase activation and subsequent MAP cascade activation 
(Morrison and Cutler, 1997). Legitimacy of the proposed death signaling pathway 
employed by the cannabinoids is further supported by the ability of THC to stimulate ERK 
activation, Raf-1 phosphorylation and Raf-1 translocation in astrocytes (Sanchez et al., 
1998b). Because the inhibitor of the ceramide biosynthesis pathway protected astrocytes 
from THC toxicity, an alternative pathway for the mechanism of cannabinoid toxicity is 
suggested. 
Utilization of the sphingomyelin pathway for induction of apoptosis has been 
recently demonstrated in many mammalian cells, including neural cells (Bragg et al., 1996; 
Jaffrezou et al., 1996). Ceramide generation through sphingomyelin hydrolysis by acid or 
neutral sphingomyelinase is usually considered the norm (Blazquez et al., 2000). A de novo 
synthesis pathway emerged as an alternative way for ceramide generation and an apoptotic 
stimulus in some cells: pancreatic, hematopoietic and astrocytes (Blazquez et al., 2000; 
Paumen et al., 1997; Shimabukuro et al., 1998). Our results indicate that the ceramide 
generated through the biosynthesis plays an important role in the THC-induced apoptosis in 
astrocytes rather than ceramide generated through the sphingomyelin hydrolysis. A link 
between ceramide formation and ROS generation has recently been suggested (Femandez-
Checa et al., 1998). We observed a significant contribution of free radicals to the toxicity of 
cannabinoids as antioxidants abrogated THC-induced cell death. Similar protection of 
hippocampal neurons with antioxidants against THC toxicity has been documented (Chan 
et al., 1998). 
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Caspases, a family of cysteine proteases, were implicated in THC toxicity because 
the broad caspase inhibitor Z-Vad-FMK protected astrocytes from death. Similarly 
anandamide, an endogenous cannabinoid receptor Iigand, induced apoptosis in PC-12 cells 
via caspase-3 activation (Sarker et al., 2000). These results implicate mitochondria as an 
important link in a mechanism of cannabinoid toxicity since both, ROS overproduction and 
activation of caspases due to the mitochondria dysfunction is well established (Garcia-Ruiz 
et al., 2000; Kolesnick and Kronke, 1998; Zamzami et al., 1995). 
In summary, these results for the first time point to the toxic effects of cannabinoids 
on astrocytes in both, in vitro and in situ studies. Activation of two kinases, PKC and ERK, 
promoters of cell proliferation in many cases, emerged as the major signaling pathway in 
the cannabinoid-induced astrotoxicity. Furthermore, our results suggest that cannabinoids 
activate a transcription-dependent cell death, a process that is, in many cases, tightly 
coupled to kinase activation. Finally, fluorescent staining revealed that cannabinoids induce 
apoptotic cell death in astrocytes. These data suggest that marijuana is more harmful to 
brain than previously thought an observation that might compromise clinical use of 
cannabinoids. 
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CHAPTER 4. ASTROCYTE ACTIVATION AND APOPTOSIS 
INDUCED BY gp!20 AND SDF-la ARE MEDIATED BY CXCR4 
RECEPTOR 
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Abstract 
Astrocytes, one of the brain glial cells, may play important role in the pathogenesis of HIV-
induced dementia and the neurotoxicity of drugs of abuse. The HIV envelope glycoprotein 
gpl20 and the stromal cell-derived factor la (SDF-la), a selective CXCR4 receptor 
agonist, produced chemokine receptor-mediated calcium transients and glutamate release in 
cultured astrocytes. Co-culturing neurons with g lia increases the neuron's responsiveness 
to SDF-la stimulatory effects by approximately 8-fold. A selective NMDA receptor 
antagonist D-AP5 abolished the stimulatory effect of SDF-la on co-cultured neurons, 
suggesting that neuronal effects of SDF-la were astrocyte-mediated. In a similar manner, 
an anion co-transporter inhibitor, NPPB, abolished the SDF-la-induced calcium transients 
both in the neurons and in the glia in the mixed neuron-glia cultures, supporting the 
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hypothesis of astrocytic glutamate contribution to the a-chemokine stimulatory action. In 
addition to the transient effect on astrocytes, SDF-la and gpl20 were toxic to astrocytes. 
Furthermore, we observed a synergy between cannabinoids and chemokines on the calcium 
transients in the astrocytes and the cell's viability. SDF-la or gpl20 in combination with 
the cannabinoid receptor agonists enhance the kinetics of calcium transients elicited by 
cannabinoids and potentiate cannabinoid toxicity in the astrocytes. Coupling of two 
systems by the activation of two different receptors, CB, and CXCR4, whose signal 
transduction pathways converge at some point might explain the synergic action shown by 
chemokines and cannabinoids. 
Introduction 
There is mounting evidence that glia in general, and astrocytes in particular, might play 
a key role in information processing (Barres, 1991; Attwell, 1994; Smith, 1994; 
Kettenmann, 1996; Ullian et al., 2001). It has been demonstrated that astrocytes can 
transmit messages to surrounding cells by direct release of signaling molecules such as the 
excitatory neurotransmitter glutamate (Parpura et al., 1994; Jeftinija et al., 1996; Jeremic et 
al., 2001). Activation of glutamate receptors is thought to be a final common pathway 
leading to neuronal damage in the course of many neurological diseases such as 
hypoxic-ischemic brain injury, epilepsy, Huntington's disease, Parkinson's disease, 
Alzheimer's disease and HTV-associated dementia. 
Progressive encephalopathy, known as AIDS dementia complex (ADC), in patients 
infected with human immunodeficiency virus type I (HFV-1) is the commonest form of 
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dementia in North Americans less than 60 years old. Numerous studies, incorporating a 
variety of complementary experimental approaches, provided compelling evidence that 
gpl20, an HIV-1 envelope glycoprotein, has neurotoxic properties. It was shown that 
gpl20 neurotoxicity was mediated by the N-methyl-D-aspartate (NMDA) receptor 
activation (Lipton at al., 1991). An indirect contribution of activated macrophages in the 
gpl20-induced neuronal apoptosis has been documented (Kaul and Lipton, 1999). In 
addition to indirect pathways, recent investigations showed that gpl20 1MB, a glycoprotein 
of HIV-1 T-cell tropic strains that signal via the a-chemokine receptor CXCR4 (Davis et 
al., 1997) and stromal cell-derived factor 1 a (SDF-la), a selective CXCR4 receptor 
agonist, directly induce apoptosis in neurons (D'Souza and Harden, 1996; Berger et al., 
1998; Hesselgesser et al., 1998; Meucci et al., 1998). 
The CXCR4 receptor is abundant in the brain and alterations in the chemokine 
receptor expression along with reactive astrocytes (gliosis) in the hippocampus of ADC 
patients have been documented (van der Meer et al., 2000; Petito et al., 2001). The 
chemokines have been found in increased amounts in the brains of patients with HIV 
encephalitis (Klein et al., 1999). The progressive encephalopathy of HIV-infected 
individuals is quite variable in course and presentation. This could be attributable to 
differences in neurotoxicity among viral strains and / or to insults that result in increased 
extracellular glutamate, such as cerebral hypoxia-ischemia, hypoglycemia and drugs of 
abuse such as marijuana (Silverstein et al., 1990; Silverstein et al., 1991; Chan et al., 1998). 
For instance, glucocorticoids were found to exacerbate neurotoxicity of gpl20 in primary 
hippocampal and cortical cultures (Brooke et al., 1997). 
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In this study, we tested the ability of CXCR4-receptor agonists, SDF-la and gpl20 
I11B, to stimulate astrocytes and to modulate cannabinoid-induced astrotoxicity. To our 
knowledge, this is the first studie relating marijuana neurotoxicity and ADC. 
Materials and Methods 
Cell cultures. Mixed neuron-glia and primary astrocyte cultures from neonatal rat cerebral 
cortex or hippocampus were established as described (Jeftinija et al., 1996). Briefly, 1-3 
day old Sprague-Dawley rats were quickly decapitated prior to removal of the brain 
according to the recommendations of the Panel on Euthanasia of the American Veterinary 
Medical Association. The cortex was freshly dissected and the tissue was enzymatically 
(papain 20 i.u./ml; lhour at 37°C) and mechanically dissociated. Cells were plated on poly-
L-lysine (1 mg/ml; MW 100,000)-coated glass cover slips (for mixed cultures) or culture 
flasks and maintained at 37°C in a humidified 5% CO%/95% air atmosphere (for primary 
astrocyte cultures). After mixed cultures reach confluence (9-12 days), the flasks were 
shaken overnight (12-18 hours) at 260 rpm at 37°C. Cultures enriched in type I astroglia 
were obtained by trypsinizing (0.25%) the attached cells for 3 min. Trypsin was inactivated 
by adding 3 ml of Eagle's aMEM supplemented with 10% heat-inactivated FBS (serum 
contains protease inhibitors). Astrocytes were plated on poly-L-lysine (10 ng/ml; MW 
100,000)-coated glass cover slips. 
The protocol used for primary neuron cultures is a modification of the procedure 
used for preparing the mixed cultures. Tissue isolated from neonatal rat cerebral cortex or 
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hippocampus was enzymatically and mechanically dissociated. The cells were plated on 
poIy-L-lysine (lmg/ml; MW 100,000)-coated glass cover slips. Neurons were cultured in 
serum-free medium consisting of Eagle's Neurobasal medium supplemented with 2% B-27 
antioxidant solution (Gibco). 
Acute cortical slices were prepared as described (Gahwiler, 1981). Briefly, cortical 
slices of250 gm were obtained from 2 weeks old Sprague-Dawleye rats. Acutely isolated 
slices were transferred to glass cover slips coated by chicken plasma that was coagulated by 
thrombin. Glass cover slips with the expiant were placed in perfusion chamber for EAA 
content determination. 
Ca2 imaging. The effect of experimental manipulation on glial [Ca2+], was evaluated by the 
fluorescence ratio imaging technique. Cells were loaded with 5 |iM Fura-2 AM (Molecular 
Probes) for 40-60 minutes at 24°C. After washing, cells were deesterified for 10 min at 
24°C. All image processing and analysis were performed using an Attofluor system with 
Zeiss microscope. Background subtracted, rationed images (340/380 nm) were used to 
calculate the [Ca2+]i according to Equation 5 of Grynkiewicz et al (1985). Calibration was 
performed in situ according the procedure provided by the Attofluor, using the Fura-2 Penta 
K+ salt as a standard. In the experiments in which we used low Ca2+ solution, calcium was 
lowered to 0.2mM while Mg2+ was elevated to 2.5mM and ImM EGTA was added. 
Release method and HPLC. Cover slips with astrocyte cultures or acute cortical slices 
were mounted into a perfusion chamber and washed in normal HEPES saline for a period 
of 20 to 30 min to allow equilibration. After equilibration, 200 jil samples were collected 
every minute. The amino acid content in the samples was determined by high-performance 
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liquid chromatography (HPLC) with fluorescence detection. Chromatography was 
performed on a 15cm Microsorb-MV HPLC column (Rainin Instrument Co.) using a pH 
5.9 sodium acetate methanol gradient. 
Toxicity assay. Cell viability was measured by the MTT assay. Astrocyte cultures were 
plated on 24-well plates and maintained in serum-containing medium for 2-3 days. 24 
hours before applying treatments, the serum-containing media were replaced with serum-
free media (QBSF-51 media, Sigma). In this medium astrocytes persist without a detectable 
change in astrocyte viability for at least 72 hours. Cultured astrocytes were incubated with 
agonists for indicated periods of time. At the end of incubation, MTT was added to the 
QBSF-51 media (250 ng/ml) and incubated for 3 hours at 37° C. After incubation, the 
medium was removed and an insoluble formazan dye was solubilized with isopropanol / 
HC1 solution. Absorbance of the converted dye was measured at 570 nm with background 
subtraction at 630 nm. One hundred percent viability is defined as MTT conversion by cells 
treated with the carrier for the duration of the experiment. 
Fluorescent staining protocol. AnnexinV-FITC staining protocol: primary astrocyte 
cultures were bathed in SDF-la-contained serum-free media (QBSF-51 media, Sigma) for 
indicated period of time and additionally incubated with the 5 pM AnnexinV-FITC dye 
diluted in Hepes-buffer solution for 15 min in the dark. Cultures were washed and mounted 
onto a perfusion chamber and examined with a Zeiss fluorescence microscope using FITC 
filter set. Images were collected with a Nikon Coolpix digital camera and the fluorescence 
signal quantified with MetaMorph imaging software. 
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Acridine orange / propidium iodide staining protocol: cultures were bathed with SDF-la 
for the indicated period of time and loaded with dyes AO (5 pM) and PI (2.5 #iM). Cells 
were visualized under fluorescence illumination: AO (480 nm for excitation and 510 nm 
barrier filter for emission); PI (540 nm and 610 nm excitation-emission filter set), with 40X 
oil immersion objective. 
Statistical analysis. All graphs and bars represent the mean ± SEM of four to six 
independent experiments. A statistical comparison between treatments was performed by 
One-way ANOVA followed by Neuman-Keuls post hoc test. Significance was establish at 
* p<0.05, "pO.Ol and '"pO.OOl. 
Results 
SDF-la and gpl20 induce Ca2+ transients and excitatory amino acids release from 
cultured type I astrocytes 
To determine the cell type responding to the application of SDF-la and gpl20, 
experiments were performed on enriched astrocyte and neuron cultures. A brief perfusion 
application of SDF-la (100 nM, 1 min) produced a rapid increase in intracellular calcium 
in cultured astrocytes. This started approximately 90 sec after the beginning of the SDF-la 
application (Fig. 1 A). SDF-la increased the level of free calcium from the basal 96 ± 2 nM 
to 196 ± 5 nM in 88 % of cells tested (n=180 of204). The effect was reversible and a 
second application of SDF-la produced an increase in [Ca2+]j that was 91± 6 % (n=178) of 
first application (Fig. 1 A). The threshold concentration of SDF-la was 10 nM (data not 
shown). ATP, a P% receptor agonist, reliably elevated calcium in all astrocytes (n=108; 
98 
Jeremic et al., 2001), confirming functional responsiveness of astrocytes to SDF-la 
application (Fig. 1A). 
Perfusion application of 20nM gpl20 (3 min) produced an irreversible increase in 
intracellular calcium with two distinguishable stages; a slow developing increase that was 
followed by a large and spike-like increase in intracellular calcium (Fig. IB). gpl20, in 
threshold concentration of 2nM, induced a small and steady increase in intercellular 
calcium without the second stage detected with 20 nM gpl20 (Fig. IB). Heat inactivated 
gpl20 was without any effect on calcium transients in astrocytes even at 50nM (Fig. IB) 
In contrast to astrocytes, neurons were much less sensitive to SDF-la application 
and only 9 % of neurons (n=8 of 85) responded with an increase in intracellular calcium 
(Fig. 1C). However, culturing neurons with glia markedly increased the number of neurons 
that responded to the SDF-la with elevation of intracellular calcium (Fig. ID). 50 mM K+ 
was used as a nonselective depolarizing stimulus to functionally identify neurons (Morton 
and Davenport, 1992; Bezzi et al., 1998; Jeremic et al., 2001). In the mixed neuron-glia 
cultures, 71% (n=84 of 118) of cells functionally identified as neurons by application of 
50mM K+ responded to SDF-la (Fig. ID). Previously, we have shown that elevated 
internal calcium in astrocytes results in release of glutamate, which then stimulates adjacent 
neurons (Parpura et al., 1994). To see whether the SDF-la-induced calcium transients in 
astrocytes are accompanied by excitatory amino acids (EAA) release, we assayed changes 
in aspartate and glutamate concentration by HPLC on the superfusate from primary 
astrocyte cultures. Perfusion application of SDF-la (lOOnM, 1 min) provoked a significant 
increase in aspartate and glutamate concentration from 80 ± 9 to 135 ±17 nM and from 100 
Fig. 1 SDF-la and gpl20 stimulates calcium transients and glutamate release from 
cultured astrocytes. (A) Perfusion application of lOOnM SDF-la and 10|iM ATP for 1 min 
reliably increased intracellular calcium in primary astrocyte cultures. (B) Application of 
20nM gpl20 for 3 minutes induced a slow increase in free intracellular calcium in primary 
astrocytes lasting 2000-3000 sec followed by a sharp oscillatory rise in intracellular 
calcium that stayed elevated throughout the experiment. 2nM gpl20 induced a slow and 
steady increase in intracellular calcium till the end of experiment (B). Heat inactivated 
gpl20 had no stimulatory effect on cultured astrocytes (B). (C) Application of 50mM K+ 
induced neuron depolarization and subsequent calcium influx in primary neuron cultures. 
In contrast, SDF-la had little stimulatory effect on calcium mobilization in neurons. (D) 
Co-culturing neurons with glia increase neuron responsiveness to the SDF-la stimulatory 
effect. (E) Addition of SDF-la (lOOnM) for 1 min in cultured astrocytes causes a one-fold 
increase in the aspartate and glutamate concentration above baseline level. (F) Perfusion 
application of gpl20 (8nM) for 3 minutes stimulated aspartate and glutamate release from 
primary astrocyte cultures. Horizontal bars indicate onset and duration of perfusion 
application of the compound. The delay in the onset of the effect is due to the dead space of 
the perfusion system. 
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± 9 to 203 ± 27 nM, respectively (n=7, p<0.05, Student t test; Fig. IE). In a similar manner, 
gpl20 (8nM, 3min) stimulated EAA release from cultured astrocytes (n=6; Fig. IF). 
Role of IPj-sensitive calcium stores in SDF-la-evoked calcium transients in cultured 
astrocytes 
The CXCR4 receptor is coupled to the pertussis toxin (PTX)-sensitive Gj/0 protein by 
activation of which this receptor exerts most of its biological action (Bokoch, 1995). We 
pre-treated cells with PTX (lOOng/ml) for 24 hours and evaluated the stimulatory effect of 
SDF-la. As expected, PTX abolished the SDF-la effect on calcium transients in cultured 
astrocytes suggesting that SDF-la induce Ca2+ mobilization trough the activation CXCR4 
receptor / Gi/o protein signaling cascade (Fig. 2A). PTX action was selective as the 
stimulatory effect of ATP was not influenced by the PTX pre-treatment (Fig. 2A). 
Removal of external calcium from batheing medium did not prevent the SDF-la 
mobilization action indicating that SDF-la mobilizes calcium from internal stores (Fig. 
2B). We further tested the contribution of internal Ca2+ stores on the SDF-la stimulatory 
effect by pre incubation of cells with 1,2-bis (2-aminophenoxy) ethane-N,N,N',N'-
tetracetic acid-acetoxymethyl ester (B APT A-AM), an intracellular calcium chelator. 
BAPTA abolished the stimulatory effect of SDF-la on astrocytes (Fig. 2C). Furthermore, 
in the presence of thapsigargin, an inhibitor of the Ca -ATPase of internal Ca2+stores 
(Thastrup et al., 1990), a second application of SDF-la failed to mobilize internal calcium 
(n=38; Fig. 2D). Chemokine receptors activate different second messenger systems, 
Fig. 2 SDF-la induces calcium transients in primary astrocyte cultures by the activation of 
PLC-IP3 signal transduction pathway. (A) Pre-treatment of astrocytes with PTX (100ng/ml; 
24 h) abolished the SDF-la stimulatory action, while it was without effect on the ATP-
induced calcium transients in astrocytes. (B) SDF-la stimulatory effect was preserved in 
low calcium solution. (C) Pretreatment of cells with B APT A-AM (50p.M, 40 min) 
abolished the SDF-la-induced calcium increase. (D) Thapsigargin (100 nM) prevented 
reloading of internal stores with calcium and blocked the second SDF-la-induced calcium 
elevation. (E) U73122 (lOpM) abolished the SDF-la stimulatory action. (F) Astrocytes 
pretreated with 50 |iM 2APB were insensitive to the SDF-la stimulatory action. Selectivity 
of antagonist was observed as 2APB erased the metabotropic component of the ATP 
response, leaving the ionotropic component of response only. (G) Dantrolene (10gM) 
failed to block the stimulatory action of SDF-la. 
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phospholipase C (PLC) among them. To examine the role of PLC, we used U73122, a 
selective inhibitor of the receptor-coupled PLC-dependent process (Smith et al., 1990). 
U73122 (lO^iM) blocked the SDF-la induced response in astrocytes, suggesting that 
activation of PLC precede the liberation of calcium from intracellular stores (Fig. 2E). To 
explore which stores are involved in SDF-la stimulatory action we used 2APB, a selective 
IP3 receptor antagonist and dantrolene, a ryanodine receptor antagonist. 2-APB (50pM) 
abolished SDF-la action and significantly reduced ATP stimulatory effect, leaving only 
inotropic component of the ATP response (n=37, p<0.01; Fig. 2F). In contrast, dantrolene 
had no significant effect on the SDF-la mobilization effect (n=45, p>0.1; Fig. 2G). 
SDF-1 a-induced release of glutamate depends on intracellular calcium 
Because PTX blocked the SDF-la-induced calcium transients in astrocytes, we 
investigated whether toxin pre-treatment might influence the chemokine-induced EAA 
release from primary astrocyte cultures. PTX abolished the SDF-la- and gpl20-induced 
glutamate release from astrocytes, suggesting that the Ga;/o subunits couple the CXCR4 
receptor to the control of EAA release from these cells (n=4, Fig. 3 A and B). This is 
consistent with recent in situ study, which showed that the SDF-la and gpl20-induced 
glutamate release from astrocytes is CXCR4-receptor mediated (Bezzi et al., 2001). 
Calcium-imaging data demonstrated that SDF-la mobilizes calcium from internal 
calcium stores by a PLC-IP3 sensitive mechanism. To investigate whether a similar 
mechanism controls the SDF-la-induced glutamate release from astrocytes, cells were 
bathed in low- calcium saline containing 0.2mM calcium with addition of ImM EGTA to 
Fig. 3 SDF-la-induced EAA release from cultured astrocytes is mediated by the Gj/0-PLC-
IP3 signaling pathway. (A and B) Pre-treatment of astrocyte cultures with pertussis toxin 
(100ng/ml; 24h) abolished the SDF-la and gpl20-evoked glutamate release from 
astrocytes. (C) Stimulatory effect of SDF-la on astrocytes was preserved in low Ca2+-
EGTA solution. In cultures incubated with the 50pM B APT A-AM for 30 min, the SDF-
la-induced glutamate release was abolished (C). (D) Incubation of astrocytes in ljaM 
thapsigargin resulted in an increase in the basal glutamate concentrations and blockage of 
the SDF-la-evoked glutamate release. (E) A specific PLC inhibitor, U73122 (IOjiM), 
diminished glutamate release from astrocytes elicited by SDF-la. (F) A selective IPs-
receptor antagonist, 2-APB, impaired the ability of SDF-la to stimulate EAA release from 
astrocytes. 
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yield an estimated free extracellular calcium level of 26nM. In the absence of extracellular 
calcium, the stimulatory effect of SDF-la was preserved, suggesting that the SDF-la-
induced release of glutamate is not dependent on extracellular calcium and therefore likely 
results in calcium release from intracellular stores (n=4, Fig. 3C). This hypothesis is further 
supported by the ability of B APT A-AM, to block the SDF-la-induced glutamate release 
(n=4, Fig. 3C). Addition of thapsigargin, an inhibitor of Ca2+-ATP-ase of internal stores 
(Thastrap 1990), increased the basal glutamate levels above control levels (p<0.05, 
Student's t-test, n=4; Fig. 3D) and erased glutamate elevation induced by SDFl-a 
supporting the notion that SDF-la releases glutamate by the mobilization of calcium from 
internal stores (n=4, Fig. 3D). 
To investigate the possible contribution of IPs-sensitive calcium stores in the SDF-la 
stimulated glutamate release from astrocytes, we employed two pharmacological inhibitors 
of PLC-IP3 signaling pathway. Both compounds, U73122, a PLC inhibitor and 2-APB, a 
selective IPs-receptor antagonist, suppressed the release of glutamate elicited by SDF-la, 
emphasizing an important contribution of IPs-sensitive calcium stores in the mechanism of 
release (n=4, Fig. 3E and F). 
Glutamate transporters are not implicated in the SDF-1 a-induced glutamate release 
from astrocytes 
Extracellular glutamate accumulation may be caused by inhibition of the uptake or 
reversal of the Na+-dependent glutamate transporter (Szatkowski et al., 1990). To examine 
the relationship between SDF-la-induced glutamate release and activity of Na+-dependent 
Fig 4. SDF-la-induced glutamate release from primary astrocyte cultures is not mediated 
by a glutamate transporter mechanism and it is anion-cotransport sensitive. (A) SDF-la 
stimulated release of glutamate from astrocytes in Na+-free solution. (B) The glutamate 
transporter inhibitor PDC (ImM) elevated the basal glutamate concentration but failed to 
block the stimulatory action of SDF-la on glutamate liberation from astrocytes. (C) Bath 
application of 5mM furosemide, an anion cotransporter inhibitor, abolished the SDF-la 
evoked glutamate release from astrocyte cultures. 
109 
280 
X 
c 
Z 180 
t 
80 J  
0  1  2 3 4 5 6 7 8  9  1 0  1 1  1 2  
B 320 
S 
Z 220 3 
â 
120 
• SDF-1 
10OnM 
Time (min) 
PDC 1 m M 
13 5 7 
260 
Z 
c 
Z 160 
5 
60 
9 11 13 15 17 19 Time (min) 
• SDF-1 
10OnM 
Control 
Furosem ide 
0 1 2 3 4 5 6 7 8 9 10 1112 13 14 15 16 
Time (min) 
SDF-1 
10OnM 
110 
glutamate transporter, we pre-incubated cultures in Na+-free medium. In Na+-free medium 
extracellular NaCl was substituted with choline chloride. SDF-la-evoked release of 
glutamate and [Ca2+]j were not influenced by pretreatment of the cultures with Na+-free 
medium suggesting that, in astrocytes, SDF-la stimulates a Na-independent glutamate 
release (n=4, Fig. 4A). In consistency with previous observations, L-/ra/is-pyrolidine-2,4-
dicarboxylate (PDC), a glutamate transport inhibitor (Isaacson and Nicoll, 1993), produced 
an increase in the baseline concentration of glutamate in the perfusate but failed to impair 
ability of the SDF-la to stimulate glutamate release from astrocytes, suggesting that 
glutamate transporter inhibitors do not mediate SDF-la-induced EAA release from these 
cells (p<0.01, Student's t-test, n=4, Fig. 4B). 
Previously we have shown that neuroligand-evoked release of glutamate from 
astrocytes is sensitive to the anion co-transporter inhibitor furosemide (Parpura et al., 1994; 
Jeftinija et al., 1996, Jeremic et al., 2001). In this study, we tested whether SDF-la-
induced release of EAA from astrocytes has a similar sensitivity by incubating astrocyte 
cultures in furosemide. Cultures bathed with furosemide (5mM) did not respond to SDF-
la, implying that chemokines stimulate EAA release from astrocytes via anion-transport 
sensitive mechanism (n=4; Fig. 4C). 
Anion co-transporter inhibitors selectively block glutamate release from astrocytes 
but not from neurons in cortical primary cultures and acute cortical slices 
Swelling of astrocytes can induce release of glutamate and aspartate by the calcium-
independent mechanism (Kimelberg et al., 1990). It has been shown that anion transport 
Fig. 5 Anion co-transporter inhibitors selectively block neuroligand-induced calcium 
increase and glutamate release from astrocytes with no effect on the depolarization-induced 
glutamate release from neurons in primary cultures or acute slices. (A and B) The SDF-la-
and ATP-stimulatory effects on calcium transients and glutamate release in cultured 
astrocytes were abolished in the presence of lOO^iM NPPB. (C and D) NPPB (lOOpM) had 
no significant effect on the depolarization-induced calcium increase and glutamate release 
from primary neuron cultures. (E and F) Furosemide (5mM) selectively blocks ATP-
induced release of glutamate from acute cortical slices (E), without affecting the 50mM K+ 
(depolarization)-induced glutamate release in acute cortical slice preparations (F). 
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blocker, furosemide, reduced cell swelling-dependent release of EAA from cortical 
astrocytes (Kimelberg et al., 1990), thus raising the possibility that SDF-la may induce a 
cell swelling-dependent glutamate release from astrocytes. We therefore tested the actions 
of the anion cotransporter inhibitor and CI channel blocker, furosemide and 5-nitro-2 (3-
phenylpropylamino)-benzoate (NPPB), on the neuroligand-induced calcium transients and 
glutamate release from astrocytes (Fig. 5). NPPB is a potent CV channel blocker at 
concentrations 10 |iM or less (Wangemann et al., 1986; Diener and Rummel, 1989) and a 
CI/ HCO3* co-transporter inhibitor at higher concentrations (Petersen and Cormann, 1987). 
At the concentration (lOpM) at which it acts as a potent CI channel blocker, NPPB failed 
to block the stimulatory effect of ATP and SDF-la (data not shown). Only when the higher 
anion-transport blocking concentration of NPPB was used were the stimulatory effects of 
SDF-la on astrocytes abolished (n=4, Fig. 5A and B). Our experiments reveled that the 
observed inhibition is selective. The co-transporter inhibitors, NPPB (only at 100|iM) and 
furosemide, blocked the SDF-la-induced calcium changes and glutamate release from 
primary astrocyte cultures (Fig. 5 A and B), whereas they had no significant effect on the 
depolarization-induced calcium transients and glutamate release from neurons in primary 
neuronal cultures (n=4, p>0.1; Fig. 5C and D) or in acute cortical slices (n=6, p>0.05; Fig. 
5F). 
Role for chemokines in the neuron-glia crass-talk 
We implemented the anion-transport sensitive mechanism of glutamate release from 
astrocytes for the evaluation of SDF-la stimulatory effect on neural cells in mixed neuron-
glia cultures (Fig. 6). Thus, we used 100|iM NPPB as a selective pharmacological 
Fig. 6 SDF-la and ATP stimulate glutamate-mediated elevation of neuronal calcium in 
mixed neuron-glia cultures. (A) NPPB (lOO^iM) abrogated the SDF-la-induced calcium 
transients in glia and in neurons, whereas it had no significant effect on the depolarization-
induced calcium influx in neurons. (B) The ATP- induced stimulatory effect on neuronal 
cells was suppressed in the presence of lOOpM NPPB while the 50mM K+-induced calcium 
rise in neurons was not affected. (C) The stimulatory effect of SDF-la on neurons in 
neuron-glia co-cultures is indirect. The chart illustrates kinetics of calcium changes in two 
neurons and two adjacent glia cells following the application of SDF-la prior to and during 
the application of 50|iM D-AP5. The response of the neurons to the SDF-la was abolished 
in the presence of D-AP5. 
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tool for the assessment of astrocytic glutamate contribution in the SDF-la-induced calcium 
mobilization in neurons. In mixed cultures, the hippocampal neurons were distinguished by 
heir characteristic morphology, typical pyramidal shaped large soma giving rise to 
numerous processes. Functional identification of neurons was achieved by application of 
50 mM K+. We have taken advantage of the observation that neurons responded promptly 
with a [Ca2>]j increase to depolarization induced by 50 mM K+ (Morton and Davenport, 
1992; Bezzi et al., 1998). Astrocytes, in mixed cultures, appeared as stellate cells that did 
not respond to application of 50mM K+. NPPB (100|4.M) abolished or significantly 
decreased SDF-la-induced calcium transients both in astrocytes 92 % (n= 24 of 26) and in 
neurons 52 % (n=14 of 27) without any significant effect on the depolarization-induced 
calcium transients in neurons (p>0.1, n=27; Fig. 6A). In similar manner, NPPB blocked the 
ATP-induced calcium transients in neurons (Fig. 6B). Those results raised the possibility 
that neuroligand-induced calcium elevation in neurons, at least in part, is indirect by the 
action of glutamate released from astrocytes in response to the SDF-la and ATP. We 
further tested this hypothesis by the employment of the specific NMDA antagonist D-AP5. 
D-AP5 (50nM) abolished the SDF-la-induced calcium elevations in 33% of neurons 
(n=l 1 of 33), significantly lowered their responses to the SDF-la in 36 % (p<0.05, n=12 of 
33) and had no effect on 31 % of neuronal population in mixed neuron-glia cultures 
(p>0.05, n=10 of 33; Fig. 6C). Taken together these results suggest that glutamate released 
from astrocytes by SDF-la modulates neurons excitability through the NMDA receptor 
activation. 
Fig. 7 SDF-la and gpl20 augment cannabinoid-induced calcium transients in primary 
astrocyte cultures. (A) SDF-la (50nM, 1 min) augmented the stimulatory effect of 5joM 
THC on calcium transients in astrocytes. (B) gpl20 (2nM, 3 min) and WIN (5pM, 10 min) 
application initiated a robust increase in intracellular calcium as compared to the effect of 
their solitary applications. The sustained calcium increase in cultures exposed to the 
combination of SDF-la or gpl20 and cannabinoids was accompanied by the loss of 
regions of interest toward the end of recording, suggesting damage in cell s membranes and 
loss of Fura-2 dye. 
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SDF-la and gplZO enhance cannabinoid-elicited calcium transients 
Because the cannabinoid receptor CBi and the chemokine receptor CXCR4 are 
coupled to the same pertussis toxin sensitive Gaj/0 protein, both may activate the same 
signaling events in cells. We tested ability of SDF-la, gpl20 and cannabinoids to provoke 
synergetic action in astrocytes by the activation of their cognate receptors, CXCR4 and 
CBi (Fig. 7). Application of SDF-la and THC augmented the kinetics of THC-induced 
calcium increase in cultured astrocytes (Fig. 7A). In a similar fashion gpl20 augmented the 
stimulatory effect of another CBi receptor agonist, Win 55,212-2 (WIN), on changes of 
intracellular calcium in cultured astrocytes (Fig. 7B). Recovery from the cannabinoid insult 
was observed in cultures treated only with WIN but not in those exposed to the 
combination of gpl20 and WIN in which the calcium concentration remained elevated 
throughout the experiment (Fig. 7B). This sustained calcium elevation, initiated by the 
WIN application in cultures pre-treated with gpl20, was accompanied with the 
disappearance of astrocytes from the visual field at the end of the experiment (data not 
shown). 
SDF-la and gpl20 induce apoptosis of astrocytes and exacerbate cannabinoid toxicity 
An observed irreversible increase in the intracellular calcium and subsequent astrocyte's 
disappearance from the imaging field elicited by the SDF-la or gpl20 in the presence of 
cannabinoids point to their toxicity (Fig. 7A and B). To determine the possible toxic effect 
of the SDF-la and gpl20 on astrocytes we performed MTT assay as a measure of cell 
Fig. 8 SDF-la and gp 120 are toxic to cultured astrocytes. (A) Incubation of astrocytes for 
24 hours with SDF-la or gpl20 induced a dose-dependent (5-50 nM) decrease in cell 
viability as revealed by MTT assay. (B and C) SDF-la augmented cannabinoid-induced 
toxicity in primary astrocyte cultures. Incubation of astrocytes with SDF-la (10 nM, 12h) 
and THC (500nM, 12h) enhanced cannabinoid toxicity by decreasing the THC threshold 
concentration from IpM to 500 nM (m p<0.01 compared to THC treatment alone, * p<0.05 
compared to SDF-la treatment alone, n=4; Fig. 8B). SDF-la (lOnM, 12h) potentiates 
cannabinoid-induced cell death evoked by 2.5 pM THC (12h) in cultured astrocytes 
(#p<0.05 compared to THC treatment alone, p<0.001 compared to SDF-la treatment 
alone, n=4; Fig. 8C). (D) gpl20 (5nM, 12h) potentates the THC-induced astrotoxicity in 
primary astrocyte cultures (*p<0.05 compared to THC treatment alone, p<0.01 compared 
to gpl20 treatment alone, n=4; Fig. 8D). 
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viability (Hansen et al., 1989). SDF-la and gpl20 induced a dose-dependent decrease in 
cell viability during 24-hour exposure, with the initial toxicity detected at 5nM 
(n=6, Fig. 8A). THC, a psychoactive component of marijuana, was toxic for cultured 
astrocytes as well (n=4, Fig. 8C). Similarly, THC-induced death of hippocampal neurons 
has been recently documented (Chan et al., 1998). SDF-la and gpl20 were found to 
contribute to the cannabinoid toxicity in astrocytes by decreasing the toxic threshold 
concentration of THC from ljiM to 500nM (Fig. 8B) and by increasing the potency of 2.5 
M-M THC (p<0.05, n=4; Fig. 8C). In similar fashion, gpl20 potentate cannabinoid toxicity 
(Fig. 8D). Co-application of gpl20 (5nM) and THC (2.5fiM) induced a significant decrease 
in astrocytes viability as compared to the effect of solitary applications (p<0.05, n=4; 
Fig.SD). 
To discriminate between the types of cell death induced by SDF-la and gpl20 in 
astrocytes, fluorescent probes were used. Treatment of primary astrocyte cultures with 
gpl20 (20nM, 24h) led to disintegration of astrocyte cultures and characteristic apoptotic 
body formation (Fig. 9A). AnnexinV-FITC conjugate is a phospholipid binding protein 
with high affinity for phosphatidylserine (PS). Extemalization of PS is one of the earliest 
indicators of apoptosis. We observed a significant increase in the fluorescence intensity in 
cells treated with the SDF-la (50nM, 24 h) as compared to control cells (p<0.01, n=5; Fig. 
9B), indicating apoptosis of astrocytes. 
For the assessment of possible necrotic events in astrocytes, cells were loaded with 
fluorescent dyes acridine orange (AO) and propidium iodide (PI). Acridine orange 
intercalates into double-stranded (intact) DNA and emit green fluorescence, whereas 
Fig. 9 SDF-la and gpl20 induce apoptotic / necrotic cell death in the primary astrocyte 
cultures. (A) gpl20 (20 nM, 24h) application induced a disintegration of astrocyte cultures 
and characteristic apoptotic body formation as reveled by phase contrast microscopy. Scale 
bar, 100pm. (B) Fluorescent images of AnnexinV-FITC labeled cells, as early marker of 
apoptotic events in astrocytes elicited by SDF-la. Exposure of primary astrocyte cultures 
to 50 nM SDF-la for 24 hours resulted in a 93 % increase in fluorescent intensity from 
control values. (C and D) Nuclear morphology of astrocytes stained with the fluorescent 
dyes, a cell-permanent DNA dye acridine orange (Fig. 9C) and cell-nonpermanent DNA 
dye propidium iodide that stains only necrotic cell with red fluorescence (Fig. 9D). SDF-
la (50nM, 48h) induced a marked decrease in the number of AO-stained fluorescent cells 
due to the SDF-la toxicity (Fig. 9C). An increase in a number of PI positive cells in the 
SDF-la treated primary astrocyte cultures illustrates that astrocytes entered a late (48 h) 
apoptotic / necrotic stage of chemokine-induced astrotoxicity (Fig. 9D). 
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bound to single-stranded DNA or RNA, it fluoresces red (Darzynkiewicz et al., 1992). 
Astrocyte cultures exposed to SDF-la (50nM, 48 hours) and stained with acridine orange 
afterwards exhibited a 67 % decrease in number of fluorescent cells compared to the 
control due to the SDF-la toxicity (Fig. 9C). In a cultures bathed with the SDF-la (50nM, 
48 hours) and stained with the necrotic cell dye propidium iodide we observed a 56 % 
increase in number of PI positive cells compared to control cultures, suggesting a late (48 
h) apoptotic / necrotic stage of the a-chemokine-induced astrotoxicity (Fig. 9D). 
Discussion 
Our data demonstrate that activation of the CXCR4 / Gaj signaling cascade in 
astrocytes by the SDF-la or gpl20 induces calcium mobilization from internal calcium 
stores and releases glutamate. SDF-la stimulates calcium transients in astrocytes within 
seconds of addition to cultures. Similarly, SDF-la releases glutamate from cultured 
astrocytes within the 1st minute of agonist delivery to the perfusion chamber, an effect that 
temporally coincides with the SDF-la -induced calcium elevation, raising the possibility 
that it is required for the glutamate release. Involvement of intracellular calcium stores in 
the mechanism of the SDF-la—induced glutamate release from astrocytes is further 
supported by the fact that B APT A-AM, an intracellular calcium chelator, and thapsigargin, 
an inhibitor of Ca2+-ATP-ase of internal stores, abolished the SDF-la-elicited calcium 
transients and glutamate release from astrocytes. These data demonstrate a capability of 
astrocytes to respond to the elevation of physiological calcium levels with glutamate 
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release, which is both necessary and sufficient to stimulate glutamate release from these 
cells (Jeftinija et al., 1996). 
U73212, a specific PLC inhibitor, blocked the SDF-la stimulatory effect implying 
an involvement of a receptor-coupled PLC-dependent process. Activation of PLC is often 
associated with the activation of Gq-coupled receptors. However, recent investigations point 
to an alternative-signaling pathway. It is established that the subunits of pertussis toxin-
sensitive Gj/oCan activate PLC (Exton, 1996), providing a signaling pathway by which the 
SDF-la may influence the activity of an enzyme. Cells of the CNS express two types of 
internal Ca2+ stores, one gated by IP3 receptors and the others gated by ryanodine receptors. 
The role of the IPs-sensitive calcium stores in the SDF-la-induced calcium mobilization 
and glutamate release from astrocytes was supported by the fact that the SDF-la 
stimulatory effect was abolished in the presence of 2APB, a selective IP3 receptor 
antagonist but not in the presence of dantrolene, a ryanodine receptor antagonist. Thus 
SDF-la stimulates calcium mobilization from the IPs-sensitive internal calcium stores and 
releases glutamate through the CXCR4 Z Gip? / PLCp / IP3 signaling cascade activation. 
Alternatively, glutamate can be released from astrocytes by the inhibition of uptake 
or reversal of the normal glutamate uptake mechanism (Szatkowski et al., 1990). This 
calcium-independent mechanism of glutamate release, was not implicated in the 
chemokine-induced EAA release from astrocytes because SDF-la required calcium to 
stimulate glutamate release, omission of Na+ from the perfusion solution did not alter the 
ability of SDF-la to stimulate EAA liberation from astrocytes, and the glutamate 
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transporter inhibitor, PDC was without effect on the SDF-la stimulatory action in 
astrocytes. 
Recent studies have shown that activation of the PLC-IP3 signaling pathway in 
astrocytes stimulates excitatory amino acid release from these cells via a calcium-
dependent, anion-transport sensitive mechanism (Jeftinija et al., 1996; Jeremic et al., 2001). 
In this study, we show that this mechanism is selective because the anion co-transporter 
inhibitors NPPB (only in higher concentrations) and furosemide blocked the neuroligand-
induced glutamate release from astrocytes but not the depolarization-induced glutamate 
release from neurons in both in vitro and in situ studies. Furthermore, anion transporter 
inhibitors blocked the neuroligand induced calcium release from intracellular stores in 
astrocytes with no effect on the depolarization-induced calcium influx in neurons. In 
conclusion, the anion co-transporter inhibitors blocked the release of glutamate from 
astrocytes by a calcium sensitive mechanism that is required for the SDF-la and ATP-
induced glutamate release from astrocytes (Jeremic et al., 2001), further postulating a 
central role for calcium in the mechanism of EAA release from astrocytes. 
The mechanism of NPPB and furosemide selectivity remains to be elucidated, 
nevertheless they were shown to be helpful pharmacological tools for the assessment of the 
astrocytic glutamate contribution in the SDF-la-induced calcium transients in neurons. Co-
culturing neurons with glia increased the population of neurons that responded to SDF-la 
stimulatory effects by approximately 8-fold. An increase in neurons' responsiveness to 
SDF-la might be glia influence, since we have demonstrated that elevation of intracellular 
calcium in astrocytes is sufficient to induce the release of glutamate leading to an NMDA-
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mediated increase in neuronal calcium (Parpura et al., 1994; Jeremic et al., 2001). In the 
mixed neuron-glia cultures NPPB (lOO^M) abolished or significantly decreased the SDF-
la-induced calcium transients in more than 90% of glia and in 50% of neurons without 
affecting the depolarization-induced Ca2+ influx in neurons, supporting the hypothesis of 
astrocytic glutamate contribution to the a-chemokine stimulatory action in neurons. 
Glutamate involvement is further supported by the fact that the selective NMDA 
antagonist, D-AP5, blocked or significantly decreased the SDF-la-induced calcium 
transient in more than 70% of neurons without altering the astrocytes response to the SDF-
la. These results agree with the recently performed in situ study which documents that 
SDF-la modulates neuronal electrical properties and synaptic transmission in rat 
cerebellum by a glutamate-sensitive mechanism (Limatola et al., 2000). Alternatively, a 
different CXCR4-receptor expression pattern might occur in neurons that are cultured alone 
versus neurons that are cultured in the presence of other brain cells. This might increase 
neuron susceptibility to the SDF-la. A direct activation of calcium transients in cultured 
neurons by SDF-la has been documented (Bajetto et al., 1999; Zheng et al., 1999). 
In addition to the transient effect of SDF-la on the astrocytes' and neurons' 
excitability that may have possible physiological implications, prolonged applications of 
SDF-la and gpl20 were toxic for astrocytes. This may have pathophysiological 
implications. Astrocytosis as well as neuronal and astrocyte apoptosis are prominent 
features of ADC (Adle-Biassette et al., 1995; Petito and Roberts, 1995), however, exact 
mechanism is still unknown. A toxicity assay confirmed the cytotoxicity of SDF-la and 
gpl20 in the primary astrocyte cultures. Specifically, we observed that SDF-la and gpl20 
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induce apoptosis in the cultured astrocytes in a 24 h period, whereas longer exposures (48h 
or latter) of cells to the SDF-la induce necrosis. Furthermore, we observed a synergy 
between cannabinoids and chemokines on the calcium transients and cells viability in the 
astrocytes. SDF-la or gpl20 in combination with THC or WIN enhanced the kinetics of 
calcium transients elicited by cannabinoids and potentiated cannabinoid toxicity in the 
astrocytes. Coupling of two systems by the activation of two different receptors, CBi and 
CXCR4, whose signal transduction pathway converges at some point, might explain 
synergetic action shown by chemokines and cannabinoids. Because the CBi and CXCR4 
receptor are coupled to the pertussis toxin-sensitive Gi/0 protein that activates PLC, both 
receptors can initiate the same downstream signaling pathway. A similar hypothesis of the 
cannabinoid contribution to the HTV-mediated immune failure has been recently put 
forward (Gurwitz and Kloog, 1998). 
In summary, our study revealed a significant contribution of the chemokine system in 
the modulation of neural cells* excitability that may have profound physiological 
implications. We argue that in addition to direct neuronal effect(s), SDF-la may induce 
calcium transients in neurons indirectly, through the NMDA receptor activation by the 
astrocytic glutamate, adding another member to the pool of neuroligands that exert a 
neuromodulatory role in the brain. In addition, we observed a synergy between 
cannabinoids, SDF-la and gpl20 on the calcium transients and astrocytes' viability that 
may introduce neuron injury by the disturbances of glia function and their ability to support 
neurons. Alternatively, glia and chemokines / gpl20 may induce neuronal injury through 
the release of glutamate and documented excitotoxicity (Lipton et al., 1991). It is likely that 
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both, direct and indirect pathways in conjunction could contribute to neuronal death. 
Finally, we believe that cannabinoids, which are used to alleviates the nausea associated 
with HIV wasting, might influence the progression and severity of neural cells' injury 
induced by SDF-la and / or gpl20 and in that way influence the course and presentation of 
AIDS dementia complex in these patients. Future analyses are needed to confirm this 
hypothesis, but in light of this evidence, the CXCR4-activated signaling pathway in 
astrocytes remains a plausible candidate for the HTV-1-induced neurodegeneration. 
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CHAPTER 5. GENERAL CONCLUSIONS 
This dissertation presents the results of investigations into the effects of 
neuroligands ATP, SDF-la and cannabinoids on astrocytes and the effect on astrocyte-
neuron interaction. Understanding of the role of astrocytes in CNS function has been 
increasing in recent years. This research contributes to this body of knowledge by showing 
that endogenous neuroligands (ATP, SDF-la) and exogenous neuroligands (cannabinoids) 
affect astrocytes directly and neurons indirectly. These effects on astrocytes were 
stimulatory and toxic, strongly suggesting a significant role for astrocytes in the brain 
physiology and pathology. 
General Discussion 
Neuroligands elicit calcium transients in astrocytes primarily from internal stores 
The Ca2+-based excitability of cultured astrocytes appears to be based on the 
regulated release of Ca2+ ions from intracellular stores (Cornell-Bell and Finkbeiner, 1991; 
Jeftinija et al., 1996; Jeremic et al., 2001). This view was confirmed since the ATP- and 
SDF-la-stimulatory effect in cultured astrocytes was blocked by B APT A-AM, a cell-
permeable calcium chelator and by thapsigargin, an inhibitor of the Ca2+-ATP-ase of 
internal stores (Thastrup et al., 1990). Both agonists were found to activate phospholipase C 
(PLC) since U73122, a selective inhibitor of receptor-coupled PLC-dependent processes 
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(Smith et al., 1990), blocked the response of astrocytes to ATP and SDF-la. Activation of 
PLC is often associated with activation of Gq-coupled receptors, a P2Y receptor for 
example. Alternatively, the fiy dimer of the pertussis toxin-sensitive Gi/0can activate PLC 
(Exton et al., 1996), providing alternative signaling pathway by which SDF-la might 
influence the activity of the enzyme. Experiments with pertussis toxin documented that 
ATP and SDF-la stimulate PLC-mediated Ca2+ transients in astrocytes via Gq and Gj/0 
protein, respectively. 
PLC activation leads to the generation of diacylglycerols (DAG) and inositol-3-
phospates (IP3), which in turn activate and liberate calcium from IPj-senstive internal 
calcium stores. Cells of the CNS express two types of internal Ca2+ stores, one gated by IP3 
receptors and the other gated by ryanodine receptors (RyR). The scenario of IP3 -mediated 
calcium release was confirmed because 2APB, a selective IP3 receptor antagonist, abolished 
SDF-la-induced Ca2+ transients in astrocytes and erased the metabotropic component of 
the ATP response, leaving only the ionotropic component. In contrast, dantrolene, a 
selective RyR antagonist, had no significant effect on the ATP and SDF-la stimulatory 
effetits in astrocytes. Furthermore caffeine, a pharmacological agonist for RyR, failed to 
stimulate astrocytes (Jeftinija et al., 1996; Jeremic et al., 2001). Taken together, these 
results suggest that neuroligands predominantly mobilize Ca2+ in astrocytes from the 
ryanodine / caffeine-insensitive internal calcium stores. 
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Mechanism of the neuroligand-induced EAAs release from astrocytes 
A major issue that is addressed in this dissertation is the mechanism responsible for the 
neuroligand-induced EAAs liberation from astrocytes. According to the literature, three different 
mechanisms control the EAAs release from astrocytes. 
First, glutamate can be released from astrocytes by the reversal of the Na+-
dependent (Kanner and Sharon, 1978) glutamate transporter that is stimulated with a 
depolarizing agent (Szatkowski et al., 1990). This probably does not account for the 
neuroligand-induced glutamate release from astrocytes because ATP and SDF-la require 
Ca2+to stimulate EAAs release, glutamate transport inhibitors had no significant effect on 
the ligand-induced EAAs release and omitting Na+ from the perfusion solution did not alter 
astrocytes' response to neuroligands. Furthermore, a brief application of strong 
depolarizing stimuli such as 50mM K+ did not provoke any significant change in the basal 
astrocytic glutamate levels. 
Second, a cell swelling-dependent release of EAAs from cortical astrocytes 
(Kimelberg et al., 1990) can account for the neuroligand-induced glutamate release. 
Furosemide, an anion transport blocker that reduces cell-swelling-induced EAAs release 
from astrocytes (Kimelberg et al., 1990), also reduces ATP-and SDF-la-stimulated 
glutamate release. Similarly NPPB, a potent CI" channel blocker at lower concentrations 
and CITHCOj" cotransport inhibitor at higher concentrations (Wengemann et al., 1986; 
Petersen and Cormann, 1987), blocked the ATP- and SDF-la-induced glutamate release 
only when anion transport-blocking concentrations were used. This raises the possibility 
that ATP and SDF-la induce swelling of astrocytes, which in turn stimulates glutamate 
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release. However, the following facts hamper this hypothesis. Neuroligands, bradykinin 
and prostaglandin PGE2 that stimulate glutamate release from glia by the same mechanism 
as ATP and SDF-la do not cause glia swelling (Parpura et al., 1995a; Bezzi et al., 1998). 
Furthermore, a review of the literature showed no single evidence that ATP and SDF-la 
evoke swelling in astrocytes or any other cell. On the contrary, ATP is involved in an 
autocrine process of regulatory volume decrease (RVD) by which cells can readjust their 
volume after transient swelling. Studies have shown that osmotic swelling of hepatocytes 
or epithelial cells stimulates release of intracellular ATP, which in turn stimulates P; 
receptors and activates CI channels in a process essential for cell volume recovery (Okada 
et al., 2001; Roe et al., 2001). Finally, the research in this disertation revealed that anion 
co-transporter inhibitors blocked the release of glutamate from astrocytes by a calcium 
sensitive mechanism that is required for the SDF-la and ATP-induced glutamate release 
(Jeremic et al., 2001), further supporting the central role for Ca2+ in the mechanism of EAA 
release from astrocytes. 
The third potential mechanism for the neuroligand-induced glutamate release is a 
Ca2+-dependent exocytosis (Attwell 1994; Parpura et al., 1994). It is demonstrated that Ca2+ 
is both necessary and sufficient to stimulate the release of EAAs from astrocytes (Jeftinija 
et al., 1996). This dissertation supports the Ca2+-hypothesis of release because neuroligands 
stimulated glutamate release from astrocytes only when [Ca2+]i was elevated. Furthermore, 
depletion of intracellular Ca2+ stores by thapsigargin or when Ca2+ mobilization was 
blocked by B APT A-AM, neuroligands no longer stimulated the EAA release from 
astrocytes. Ca2+ imaging experiments revealed that there are certain [Ca2+]j changes that do 
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not result in glutamate release from astrocytes suggesting that a certain [Ca2+]i threshold 
should be reached for glutamate release. This agrees with recent study showing that Ca2+-
regulated release of glutamate from astrocytes is engaged at physiological Ca2+ levels 
(Parpura and Haydon, 2000). The nature of the Ca2+-dependent glutamate release from 
astrocytes remains to be defined. Is this Ca2-dependent glutamate release from astrocytes 
vesicular? If so, is it similar to the neuronal vesicular release of transmitters? 
The Ca2+ requirement for neuroligand-induced glutamate release from astrocytes 
supports exocytosis and existence of synaptic machinery in astrocytes supports vesicular 
transmitter release. The vesicular hypothesis of glutamate release from astrocytes gained 
respect from recent findings. SNARE proteins, syntaxin, synaptobrevin II and SNAP-23 (a 
homolog of SNAP-25) that are essential for vesicle fusion, are present in astrocytes 
(Parpura et al., 1995b; Jeftinija et al., 1997; Hepp et al., 1999). Clostridial toxins, which 
cleave SNARE proteins, blocked the Ca2+-dependent glutamate release from astrocytes 
(Jeftinija et al., 1997; Bezzi et al., 1998; Araque et al., 2000). The potent secretagogue a-
latrotoxin, which induces the exocytosis of vesicles at nerve terminals, also stimulates 
glutamate release from astrocytes (Parpura et al., 1995c). Bafimolycin Al, a toxin that 
inhibits the electrochemical proton gradient maintained by V-ATPase that is required for 
the vesicular uptake of neurotransmitters, greatly reduced glutamate release from astrocytes 
(Araque et al., 2000, Bezzi et al., 2001). Finally, electron microscopic analysis revealed the 
presence of dense-core and clear vesicles in cultured astrocytes which membranes are 
associated with synaptobrevin II and synaptophysin (Maienschein et al., 1999). These 
findings point to an existence of the vesicular apparatus that could control transmitter 
release from astrocytes in a process that is similar to the one in neurons. 
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Neuroligands ATP and SDF-la modulate excitability of neurons by glial glutamate 
Astrocytes outnumber neurons in many brain regions and they are interconnected 
via gap junctions to form extensive networks. In light of evidence for neuron-glia 
interaction, it is possible that the degree of coupling between astrocytes could set a tone for 
the neuronal activity (Giaume and McCarthy, 1996). Ca2+ released from intracellular stores 
may initiate a wave of elevated cytosolic Ca2+ that propagates both within individual 
astrocytes and between astrocytes (Cornell-Bell et al., 1990; Dani et al., 1992). This Ca2+ 
wave, as it propagates through the network of astrocytes, interacts with adjacent neurons 
which in turn respond with increased neural Ca2+ (Parri et al., 2001). 
It is known that ATP serves as an extracellular signal that coordinates the 
intracellular propagation of the Ca2+wave (Guthrie et al., 1999), thus contributing to long-
range Ca2+ signaling. This dissertation postulates a new role for ATP in the process of 
neurotransmission. The Ca2"1" imaging experiments in mixed neuron-glia cultures provided 
evidence for the role of ATP in short-range Ca2+ signaling because the depolarization-
induced release of ATP from neurons stimulated adjacent astrocytes. In addition, ATP was 
found to indirectly modulate neuronal excitability by the glial glutamate that induced the 
NMDA-receptor-mediated Ca2+mobilization in the adjacent neurons, forming a putative bi­
directional signaling loop. A positive feedback loop between the release of glutamate and 
ATP by astrocytes is also implied because Queiroz et al. (1997) have shown that ATP is 
released from astrocytes by glutamate receptor activation. Therefore, it is feasible to 
propose that ATP propagate signals in the brain both in an autocrine and in a paracrine 
fashion. 
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In a similar manner, SDF-la, a a-chemokine agonist, activated glia to release 
glutamate that stimulated neighboring neurons. This agrees with a recently performed in 
situ study which documents that SDF-la modulates neuronal electrical properties and 
synaptic function in rat cerebellum by a glutamate-sensitive mechanism (Limatola et al., 
2000). 
Astrocytes contribute to the neurotoxicity of THC and gpl20 
Damage to the CNS leads to cellular changes not only in the affected neurons but 
also in adjacent glial cells. Astrocytes respond to the insult rapidly with formation of glial 
scars (McGraw et al., 2001) or apoptosis (Raghupathi et al., 2000). Recently, brains of 
patients with AIDS have been shown to manifest neuronal injury and apoptotic-like cell 
death (Adle-Biassette et al., 1995; Petito and Roberts, 1995). The toxicity assay in this 
dissertation has documented death of astrocytes induced by THC, a psychoactive 
component of marijuana, and gpl20, an HTV-1 envelope glycoprotein, which postulates 
their contribution to the brain injury elicited by drugs of abuse and HTV-1. 
Both ligands induced apoptosis in the astrocytes in a time- and a dose-dependent 
manner, in the concentrations comparable to those found in the plasma of marijuana 
abusers and AIDS patients (Chiang and Barnett, 1984; Lipton, 1998). Distinct death-
signaling pathways emerged for the toxicity of THC in the neurons and the astrocytes. 
Activation of the PLA2-COX system induced apoptosis in the cultured hippocampal 
neurons (Chan et al., 1998), whereas two proliferate systems, PKC and ERK, mediated 
cannabinoid-induced astrotoxicity. It is generally accepted that the activation of the ERK 
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cascade leads to cell proliferation (Derkinderen et al., 1999). However, recent 
investigations documented situations when ERK mediates cell cycle arrest (Pumiglia and 
Decker, 1997) and cell death (Murray et al., 1998). These studies define situation in which 
cell fate is controlled by the duration of the stimulus, rather than the stimulus per se. This 
view is supported by the recent study showing that prolonged activation of ERK cascade in 
C6 glioma cells by cannabinoids induces cell death (Galve-Roperh et al., 2000). 
Mounting evidence suggests that cognitive dysfunction developing as a result of 
HIV-1 infection is mediated at least in part by generation of excitotoxins and free radicals 
in the brain. The mechanism involves excessive activation of the NMDA receptor-operated 
channels, with resultant excessive influx of Ca2+ and the generation of free radicals, leading 
to neuronal damage (reviewed by Lipton, 1998). Lipton et al. (1991) first documented that 
gpl20 neurotoxicity was mediated by the NMDA-receptor activation. In this study, the 
CXCR4 receptor agonists, SDF-la and gpl20 IIIB, were found to stimulate glutamate 
release from astrocytes providing the possible source for the HIV-l-induced excitotoxins 
formation in the brain. Furthermore, gpl20 and SDF-la induced apoptosis in astrocytes 
may introduce neuron injury indirectly by the removal of the well-recognized supportive 
role of astrocytes. It is likely that both, direct and indirect pathways in conjunction could 
contribute to the SDF-la- and gpl20-induced neuronal death. 
The SDF-la- and gpl20-induced astrocytes' death was exacerbated by 
cannabinoids in a synergy that may occur between gpl20 and THC from marijuana, which 
is used in the clinical treatment of nausea associated with AIDS wasting. The exacerbation 
of gpl20 and SDF-la astrotoxicity by cannabinoids may have a significant implication on 
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the course and presentation of dementia in the AIDS patients. A similar hypothesis of a 
cannabinoid contribution to the HIV-1-mediated immune failure has been recently put 
forward (Gurwitz and Kloog, 1998). Also, endocrine modulation of neurotoxicity of the 
gp 120 has been recently reported (Brooke et al., 1997). Taken together these findings 
suggest that the simultaneous activation of putative neurochemical systems in the brain 
eventually causes neural damage and apoptosis that may affect the progression and severity 
of some CNS diseases. 
Summary 
ATP stimulates cultured type I astrocytes 
The purpose of this study was to provide a mechanism that is responsible for the ATP-
induced EAA release from astrocytes. Furthermore, we tested ATP as a signaling molecule 
in the process of neuron to glia communication. Application of 100 ATP for two 
minutes evoked a two-fold increase in concentration of aspartate and four-fold increase of 
glutamate above base line. The EAAs release from astrocytes was preserved in low calcium 
saline suggesting involvement of intracellular calcium stores. Ca2+ requirement for the 
EAAs release from astrocytes is further supported by the fact that BAPTA-AM, a cell 
permeable intracellular chelator, and thapsigarin, an inhibitor of Ca2+-ATP-ase of internal 
calcium stores, abolished the stimulatory effect of ATP on the cultured astrocytes. In 
agreement with release experiments, ATP mobilizes calcium in cultured type I astrocytes as 
revealed by a Ca2+ imaging technique. The stimulatory effect of ATP on calcium transients 
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and glutamate release in astrocytes is P2 receptor-mediated because suramin, a selective P2 
receptor antagonist, blocked the response of cells to ATP. 
Reversal of glutamate transporters does not account for the release of EAAs because 
omitting Na+ from the perfusion solution or using glutamate transport inhibitors had no 
significant effect on the ATP-induced glutamate release. However, the ATP-induced 
glutamate release from astrocytes was sensitive to anion transport inhibitors, furosemide 
and NPPB, which raises the question of cell swelling-dependent EAA release from 
astrocytes. 
Finally, a role for ATP as a mediator of neuron to glia signaling has been postulated. 
Using mixed neuron-glia cultures we observed that depolarization of neurons with 50mM 
K+ directly stimulated a rise in the [Ca2+]j in neurons and indirectly in adjacent glia by the 
ATP that is released from neurons. A putative, bi-directional link in neuron to glia 
communication was revealed by the fact that ATP elevates neuronal Ca2+ indirectly by the 
action of glutamate, which is released from astrocytes in response to ATP. 
Cannabinoids and astrocytes 
The objective of the second study was to evaluate any stimulatory effect of 
marijuana on brain cells. It was established that THC, the main psychoactive component of 
marijuana, and WIN 55,212-1 (WIN), a synthetic cannabinoid receptor ligand, potently 
stimulated astrocytes and induced injury in the same cells. Both cannabinoid ligands 
stimulated the CBi receptor-mediated biphasic Ca2+ response in astrocytes. Experiments 
with low Ca2+ saline revealed involvement of two different Ca2+ pools in the cannabinoid 
stimulatory action: the observed rapid increase in [Ca2+], induced by cannabinoids 
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originated from the intracellular stores, while the irreversible Ca2* increase resulted from 
the extracellular calcium entry. U73122, a selective pbospholipase C (PLC) inhibitor, 
attenuated the stimulatory effect of WIN, suggesting the role for the receptor-coupled PLC 
dependent processes in the cannabinoid-induced Ca2+ transients in astrocytes. 
Besides the stimulatory effect of cannabinoids on the Ca2+ transients in astrocytes, 
cannabinoids induced apoptosis in astrocytes in both in vitro and in situ studies. A toxicity 
assay documented an activation of multiple signal transduction pathways in the 
cannabinoid-induced astrotoxicity. Activation of a novel class ofPKC s and ERK was 
crucial in the cannabinoid toxicity. Contributions of pro-apoptotic factors, like the ceramide 
and the free radicals, have been also documented. Finally, the toxicity assay revealed the 
ability of astrocytes to recover from the cannabinoid insult as the viable astrocytes 
repopulated areas in which the THC irreversibly damaged the cells. This astrocyte feature 
mimics in vivo ability of glia to rapidly respond to brain injury with activation (astrogliosis) 
and proliferation forming glial scares, a hallmark of many neurodegenerative changes in the 
brain. 
SDF-la and gpl20 activate and kill astrocytes through CXCR4 receptor 
In this study, the ability of CXRC4 receptor ligands, SDF-la and gpl20 llLB, to 
stimulate Ca2+ transients and release glutamate from cultured astrocytes was tested. Both 
agonists were found to increase [Ca2+]i and to release glutamate from astrocytes in a dose-
dependent manner. The stimulatory effect of SDF-la and gpl20 on astrocytes was 
abolished with pertussis toxin pre-treatment, implying activation of the CXCR4-receptor / 
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Gj/o protein signaling cascade. U73122, a PLC inhibitor and 2APB, an IPj receptor 
antagonist, blocked the stimulatory effect of SDF-la in cultured astrocytes suggesting that 
a-chemokines mobilize Ca2+ and release glutamate by the activation of the PLC-IP3 
signaling pathway. 
The SDF-la stimulated astrocytes primarily, whereas neurons were much less 
sensitive to the SDF-la. However, in the presence of glia, the number of neurons 
responding to the SDF-la increased by approximately 8-fold. Experiments performed on 
mixed neuron-glia cultures revealed that glia and glutamate indirectly contributed to the 
stimulatory effect of SDF-la in neurons. NPPB, an anion co-transport inhibitor that 
selectively block the release of glutamate from astrocytes, and D-AP5, a specific NMDA 
antagonist, abolished or significantly decreased SDF-la stimulatory effect in 50 % and 70 
% of neuronal population, respectively. 
To explore the factors that contribute to the AIDS dementia complex syndrome, 
toxicity of the ligands was evaluated. Prolonged applications of either SDF-la or gpl20 
(12h or more) were toxic for astrocytes. Cells exhibited characteristic features of apoptosis, 
formation of apoptotic bodies and extemalization of the apoptotic marker 
phosphatidylserine (PS) as revealed by an increase in binding of AnnexinV-FITC 
conjugate. 
Finally, we observed a synergy of SDF-la, gpl20 and cannabinoids on the Ca2+ 
transients and the astrocytes' viability. Co-application of SDF-la or gpl20 and THC or 
WIN enhances the kinetics of Ca2+ calcium transients elicited by cannabinoids and 
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furthermore potentiates cannabinoid toxicity in astrocytes, which implicates a possible role 
for cannabinoids and chemokines in the etiology of ADC. 
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